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Abstract
The Effects of the Gut Microbiota on the Host Chromatin Landscape
by
Nicholas Paul Semenkovich
Doctor of Philosophy in Biology and Biomedical Sciences
Molecular Genetics and Genomics
Washington University in St. Louis, 2017
Professor Jeffrey I. Gordon, Chair
The human gut microbiota is home to tens of trillions of microbes belonging to all three domains
of life. The structure and expressed functions of this community have myriad effects on host
physiology, metabolism, and immune function. My studies focused on a facet of host-microbial
interactions and mutualism that has not been explored to a significant degree in part because of the
absence of suitable tools: namely, if, when, and how the gut microbiota produces durable effects
on host biology through its impact on the epigenome. To address this area, I turned to gnotobiotic
mice and developed a variety of experimental, methodological, and computational approaches to
characterize the chromatin landscape of various host cell populations. I selected small populations
of T cells likely to be exposed to the gut microbiota and its products, principally TCR αβ+ and TCR
γδ+ small intestinal intraepithelial lymphocytes (IELs). I also chose to study circulating CD4+ and
CD8+ T cells, with the advantage that these populations can be isolated from donors without using
highly invasive techniques. I designed a series of approaches to enrich, isolate, and purify each of
these cell populations from single animals, and to subsequently compare their chromatin landscape
within and across mice using a recently described Assay for Transposase-Accessible Chromatin
with high throughput sequencing (ATAC-seq), focusing on enhancer and super-enhancer loci within the mouse genome. These analyses revealed a conserved set of super-enhancer loci between αβ
and γδ IELs, including super-enhancers near genes responsible for phospholipid binding and T cell
vii

receptor signaling. In comparing C57BL/6J male mice reared under germ-free (GF) conditions to
age- and sex-matched conventionally raised (CONV-R) mice (i.e., animals that acquired microbes
from their environment beginning at birth), I was able to directly assess the impact of colonization on chromatin ‘state’ in these different purified cell populations and to identify colonizationdependent effects in IELs on enhancers associated with genes involved in a number of metabolic
and signaling pathways. I then compared the results to GF mice that had been colonized following
the end of the weaning period with an intact cecal microbiota from a CONV-R C57BL/6J donor.
The resulting conventionalized (CONV-D) animals allowed me to identify modifications to host
chromatin landscape that are ‘induced’ following the suckling-weaning transition and, in doing so,
ascertain whether there were developmental windows that could constrain the durable effects of
the microbiota on chromatin accessibility. In doing so, I observed changes in chromatin accessibility with colonization that may reveal a functional maturation of IEL populations that is related to
the timing of exposure to the microbiota during postnatal development. My thesis project involved
development of an elaborate, multi-faceted computational pipeline for the analysis of these novel,
large datasets, including the prediction and characterization of putative enhancers and super-enhancers, proximally associated genes, and metabolic pathways influenced by those elements. As a
whole, this work defines the impact of gut microbial colonization on host chromatin landscape and
provides an analytical toolkit for further studies.
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Chapter 1

Introduction
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Introduction
The gut microbiota and host can be thought of as a ‘holobiont,’ where both host and microbes
coexist and interact in a complex range of relationships, ranging from symbiotic and mutually
beneficial (e.g., the biosynthesis of vitamins and co-factors) to harmful or parasitic. This spectrum
of interactions has been present as both host and bacteria have evolved over millennia, and has
resulted in numerous systems — largely immunologic — that regulate and influence these relationships. While some of these regulatory systems have been described over the past few decades,
one possibility that remains largely unexplored is that host-microbiota interactions are influenced
by epigenetic factors — that is, the microbiota and its products may alter the host chromatin
landscape to subsequently potentiate and perpetuate phenotypes. Some critical questions in this
field include: Do periods of nutritional unavailability and dysbiosis potentiate longer-term impacts
in the host via epigenetic mechanisms? Are host-chromatin modifications durable (does the host
keep an epigenetic ‘memory’ of prior exposure to a given microbial community configuration or
configurations)? Is there a critical temporal window of exposure, where microbial signals must
be received by the host before they are able to alter the chromatin landscape in a permanent way?
These key questions are what drove my exploration and interest throughout this thesis.
Epigenetic interactions between the gut microbiota and its host
Several studies have presented a range of evidence for epigenetic interactions between the gut
microbiota and its host. There are a multitude of analytical techniques available to characterize
the epigenome (reviewed in Winter et al. 2015). In light of their strengths and weaknesses, it is
important to consider each report in the context of the methods applied.
A number of studies have looked at changes in DNA methylation in host tissues, and its
association with microbiota composition. Given high input material requirements of many methylation-based techniques (Tsompana & Buck 2014), some of these studies necessarily focus on
heterogeneous host cell populations, where a large amount of cellular material is available — but
mixed input populations can complicate interpretation of results. Some of the earliest studies of
2

microbiota-epigenetic interactions focused on the immune system, using microarray-based assays
for methylation. Kellermayer et al. (2011), interrogated the methylation patterns of the colonic
mucosa in wild type C57BL/6 mice, and in a Tlr2(-/-) mouse model (of interest given its associations with IBD and intestinal barrier function (Cario 2008)), using a custom microarray. They
determined that, compared to WT mice, Tlr2(-/-) mice showed significant methylation differences
around a number of genes associated with inflammatory pathways (e.g., Alanyl Aminopeptidase
[Anpep], and annexin A8 [Anxa8]); these changes were associated with a decrease in the relative abundance of Firmicutes and increases in the representation of members of Proteobacteria,
Bacteroidetes, and Actinobacteria. However, their study was not designed to separate microbiotainduced changes from the effects of the Tlr2 knockout alone.
In another example of a methylation-based approach, (Kumar et al. 2014) looked at whole
blood methylation patterns across pregnant women, segregated based on whether their fecal microbiota appeared to be dominated by Bacteroidetes and Proteobacteria, versus Firmicutes. In
women whose microbiota harbored Firmicutes as the dominant phylum (as compared to a Bacteroidetes/Proteobacteria dominated group), they identified differential methylation patterns around
genes associated with increased risk for obesity and the metabolic syndrome. Other studies have
focused on dietary contributions to host methylation, including Schaible et al. 2011, where female
mice were placed on a methyl-donor diet (a diet supplemented with folic acid, B12, betaine, and
choline) during pregnancy. The offspring of these conventionally-raised mice were observed to
have alterations in DNA methylation patterns (associated with a variety of loci, including Ppara),
an increased susceptibility to dextran sodium sulfate-induced colitis, and structural changes in the
microbiota (including an increased proportional representation of Clostridia and a decreased representation of Lactobacilli); these differences did not last beyond 90 days.
Numerous associational studies have also been performed in humans, highlighting epigenetic and microbial factors in a range of (generally gastrointestinal) diseases. Based on observations that Fusobacterium was detected frequently in biopsies and excised tumors of patients with
colorectal cancer (Castellarin et al. 2012), Tahara et al. (2014) characterized intestinal methylation
3

differences in patients with colorectal cancer, stratified by the presence of Fusobacterium in tumor
sections. They discovered that tumors enriched for Fusobacterium had CpG island methylator
phenotypes (CIMP), and an increase in microsatellite instability.
A small number of recent studies have tried to more directly define links between the
microbiota and epigenetic changes, leveraging sterile ‘germ free’ (GF) mice while profiling epigenetic features. Obata et al. (2014) identified a specific DNA methylation adapter (Uhrf1) that
was upregulated in intestinal Treg cells upon conventionalization of GF mice. Upon deletion of
this locus in Tregs hypomethylation was observed in the promoter region of Cdkn1a, resulting
in cell-cycle arrest and severe colitis. Camp et al. (2014) performed ChIP-seq and RNA-seq on
intestinal epithelial cells (IECs), in GF and CONV-R mice. Their study determined that transcriptional changes were not associated with changes in ileal or colonic chromatin accessibility within
epithelial cell populations. Yu et al. (2015) used whole-genome bisulfite sequencing to characterize methylation differences in GF versus conventionally raised (CONV-R) C57BL/6J mice. Focusing on Lgr5+ intestinal stem cells (ISCs), the group identified an increase in ISC methylation
at CpG islands during the suckling period that were correlated with changes in transcription of
certain glycosylation genes. They also performed a time-series analysis of GF vs CONV-R mice,
which identified a reduction in methylation at numerous sites in GF mice and that these alterations
were correlated with gene expression changes in at least two loci (B4galnt1 and Phospho1). They
observed a rescue of this phenotype (an increase in methylation and associated changes in gene
expression) in small cohort of GF mice (n=3) that were subsequently colonized at 25 days of life,
and sacrificed at 100 days (a 75-day colonization period).
Potential mechanisms by which the gut influences the host epigenome
In part through the studies above, a number of mechanisms have been proposed by which the
microbiota may influence the host epigenome (Alenghat & Artis 2014). One recurring theme in
the literature is that elaborated microbial products and metabolites can directly influence the host
epigenome. These metabolites, their influences, and proposed mechanisms, range from straight4

forward (e.g., methyl donors that provide methyl groups for epigenetic modifications), to complex
microbial processing of food components that subsequently signal host cells.
The most fundamental proposed mechanism for gut-host epigenetic signaling is through
the simple availability of methyl donors. A variety of gut-derived products serve as methyl donors
or cofactors for base-pair methylation and the remodeling of chromatin, including folate and a
variety of B vitamins (B2, B6, and B12), methionine, choline, and betaine (Anderson et al. 2012).
These are all components of one-carbon metabolism pathways that contribute to the availability
of S-adenosylmethionine (SAM), and transporters for many of these methyl donors are expressed
within the colonic epithelium (Said et al. 2000; Visentin et al. 2014; Albersen et al. 2013). SAM
itself is utilized by methyltransferases in the maintenance and establishment of DNA methylation.
A large body of work has observed associations between dietary intake of these methyl donors and
host DNA methylation patterns, including the studies described above (reviewed in Anderson et al.
2012). Notably, the microbiota can also produce or modify some of these methyl donors directly,
including folate and a variety of B vitamins (Jeffery & O’Toole 2013).
Beyond direct contributions to the methyl donor pool, diet and the microbiota may contribute to more nuanced epigenetic signaling through metabolites, including short chain fatty acids
(SCFAs). SCFAs are elaborated by commensal bacteria through their anaerobic fermentation of
plant polysaccharides, and include propionate, acetate, and butyrate. Beyond being used as critical
energy source by the host (Donohoe et al. 2011), these metabolites can signal through GPCRs, and
act as histone deacetylase inhibitors (HDACs) (Vinolo et al. 2011). Through these mechanisms,
commensal bacteria may influence host phenotypes: Alenghat et al. (2013) demonstrated that the
absence of HDAC3 in IECs resulted in broad dysregulation in gene expression and increased sensitivity in a DSS-induced colitis model, a phenotype that was abrogated in GF mice. Additionally,
a number of models have identified specific signaling mechanisms with immunologic impacts, for
example, Arpaia et al. (2013) demonstrated one route through which butyrate enhanced extrathymic differentiation of Tregs.
5

Overview of the thesis
Based on this background, I set out to explore the potential contributions of the microbiota to the
host chromatin landscape, using a mouse model. I chose to analyze this in the most controllable,
reproducible approach, using sterile (‘germ-free’) mice and comparing them to their conventionally raised (CONV-R) counterparts. To better understand potential ‘critical window’ effects, I also
included a ‘conventionalized’ arm, consisting of mice that were raised germ-free, and then subsequently colonized (‘conventionalized’, CONV-D) following the three-week suckling-weaning
transition.
I turned to a nascent technology when this thesis began to profile chromatin accessibility across multiple cell populations in these mice. ATAC-seq (Assay for Transposase-Accessible
Chromatin using Sequencing (Buenrostro et al. 2013)) is a transposase-based technique similar to
DNAse-seq. In ATAC-seq, the Tn5 transposase is pre-loaded with Illumina sequencing adapters
and incubated with isolated nuclei. The transposase can then insert these sequencing adapters into
regions of chromatin that are ‘open’ (areas of uncondensed, accessible chromatin). The resulting
fragments of DNA can be amplified and sequenced, which reveals a genome-wide map of the open
chromatin landscape (see Figure 1).
I focused on cell lineages potentially exposed to the microbiota and its products (and cells
that could drive responses to microbial colonization) and selected four cell populations that met
those criteria: circulating peripheral lymphocytes (both CD4+ and CD8+ T-cells), and intestinal
intraepithelial lymphocytes (TCR αβ+ and TCR γδ+ T-cells).
I developed a protocol to rapidly and simultaneously isolate these populations from single
mice, to ensure I could generate data without pooling samples across mice. Within these cell populations, I focused my analyses on enhancers — regions of chromatin that can drive the expression
of genes (including non-classical elements like lncRNAs) via the recruitment of activating factors,
and characterized the enhancer landscape of these cells for both colonization dependent and independent features.
6

The computational challenges I faced were great: assuming ATAC-seq data could be generated, no pipeline existed for its analysis and processing. Additionally, existing pipelines for related types of data (e.g., DNAse-seq) tended to be fragile and poorly documented, which largely
precluded their adaptation to ATAC-seq data. Additionally, the computational resources for superenhancer prediction were designed for different data types (ChIP-seq) and differential accessibility
analyses tended to be performed on an ad-hoc basis. I developed a flexible, portable, and documented computational pipeline for the analysis of ATAC-seq data, including its pre-processing,
enhancer and super-enhancer characterization, and differential accessibility prediction, with the
goal of establishing a permanent toolkit for other researchers, as the use of ATAC-seq and DNAseseq grows.
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Figure legend
Figure 1. A broad overview of an ATAC-seq analysis is shown, where cells are first isolated and
nuclei are prepared. Then, nuclei are incubated with the Tn5 transposase, and subsequently sequenced. Next, areas of high signal compared to background (‘peaks’) are called, and aggregated
across samples, followed by the identification of nearby genomic features. The transposase graphic
is adapted from Buenrostro et al. 2013.
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Abstract
The gut microbiota impacts many aspects of host biology including immune function. One hypothesis is that microbial communities induce epigenetic changes with accompanying alterations
in chromatin accessibility, providing a mechanism that allows a community to have sustained host
effects even in the face of its structural or functional variation. We used Assay for TransposaseAccessible Chromatin with high-throughput sequencing (ATAC-seq) to define chromatin accessibility in predicted enhancer regions of intestinal αβ+ and γδ+ intraepithelial lymphocytes purified from germ-free mice, their conventionally raised (CONV-R) counterparts, and mice reared
germ free and then colonized with CONV-R gut microbiota at the end of the suckling–weaning
transition. Characterizing genes adjacent to traditional enhancers and super-enhancers revealed
signaling networks, metabolic pathways, and enhancer-associated transcription factors affected by
the microbiota. Our results support the notion that epigenetic modifications help define microbial
community-affiliated functional features of host immune cell lineages.
Significance
Comparing germ-free mice with those colonized at birth or later provides a way to determine
how gut microbial community exposure affects the chromatin landscape of cells along the gut or
at remote sites, ascertain how alterations in chromatin accessibility are correlated with functional
features of different lineages, and determine whether there is a critical window of exposure when
microbial signals must be received to alter the landscape durably. Genome-wide analysis of chromatin accessibility in intraepithelial lymphocytes and circulating T cells purified from gnotobiotic
mice revealed enhancers and flanking genes involved in signaling and metabolic pathways that
are sensitive to colonization status. Colonization does not fundamentally alter lineage-specific
cis-regulatory landscapes but induces quantitative changes in the accessibility of preestablished
enhancer elements.
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Human gut microbial communities interact with their hosts in ways that affect physiology,
metabolism, and immune function. The underlying mechanisms are subjects of intense investigation. One hypothesis is that the gut microbiota induces epigenetic changes in host cells, altering
chromatin accessibility and the subsequent poising of genes for expression. Chromatin modifications have the potential to outlast a given microbiota configuration and endow the host with a
“memory” of microbial exposure (1). This hypothesis has been investigated in a limited number of
studies. DNase-seq applied to intestinal epithelial cells identified few differences in the chromatin
landscape between germ-free (GF) and conventionally raised (CONVR) mice (2). Another study,
using bisulfite sequencing, analyzed pooled populations of Lgr5+ intestinal stem cells and found
colonization dependent methylation of numerous CpG loci (3). More recently, iChIP-IVT (Indexing first Chromatin Immunoprecipitation-In Vitro Transcription) was used to assess chromatin
state in all three subsets of innate lymphoid cells harvested from CONV-R and antibiotic-treated
mice. The results identified thousands of H3K4me2 regions that were sensitive to antibiotic treatment, with a number of these regions losing their specificity for different innate lymphoid cell
subsets (4).
In the present study, we use ATAC-seq (Assay for Transposase Accessible Chromatin
with high-throughput sequencing) to examine this hypothesis. ATAC-seq uses a Tn5 transposase
preloaded with sequencing adaptors; this approach enables efficient in vitro transposition of the
adaptors into regions of accessible (“open”) chromatin (5) which correlate with primed or active
enhancers. ATAC-seq is agnostic to the type of epigenetic modification and, importantly, allows
analyses to be performed on small populations of cells. Our focus on the effects of the gut microbiota on enhancers was based on the supposition that identifying these regions, their neighboring
genes, and the signaling and metabolic pathways to which these genes belong would provide
mechanistic insights about how the gut microbial community influences the biological properties
of immune cell populations. We targeted two populations that are in intimate association with the
gut microbiota and its products: T-cell receptor (TCR) αβ+ and TCR γδ+ intraepithelial lymphocytes (IELs). IELs participate in immune surveillance, immune tolerance, wound repair, mainte15

nance of gut barrier function, and protection from infectious agents (6). Given these roles, it is
not surprising that considerable attention has been directed to how the microbiota shapes the IEL
compartment (7, 8), although the relationship between the microbiota and IELs is less well characterized than other components of the immune system. We also examined peripheral CD4+ and
CD8+ T cells, reasoning that they may have transient exposures to products of the gut microbiota,
can be sampled more readily than IELs, and would allow us to delineate extraintestinal epigenetic
effects of the microbiota.
Results
Experimental Design and Approach to Analysis.
Three groups of 8- to 10-wk-old male C57BL/6 mice were studied: a group reared under sterile
conditions (GF mice), a CONV-R group exposed to microbes present in their environment from
the time of birth, and a group initially maintained GF until the suckling–weaning transition at 3 wk
of age and then colonized with a cecal microbiota from a CONV-R donor (conventionalized mice,
CONV-D) (n = 8 mice per treatment group). The relatively low numbers of cells required to perform ATAC-seq allowed us to study different cell populations from single animals without needing
to pool samples (Fig. S1A) and to identify predicted enhancers within a given cell lineage, including those whose accessibility is altered by microbial exposure during postnatal development.
To analyze the large datasets generated (Dataset S1), we developed an open-source, Python-based computational pipeline named RIESLING (Rapid Identification of Enhancers Linked
to Nearby Genes). RIESLING was inspired by the ROSE (Rank Ordering of Super-Enhancers)
software designed for ChIP-seq (9, 10) and developed as a toolkit to standardize analysis of datasets generated from ATAC-seq. RIESLING is designed to enable de novo prediction of putative
enhancers and characterization of their differential accessibility (Fig. S2). Briefly, sequencing data
generated following ATAC-seq transposition are used to call “peaks” (open regions of chromatin
with a read density statistically higher than background) identified using a Poisson model adapted
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from standard approaches used for ChIP-seq and DNase-seq analyses. To predict putative enhancers, peaks and their underlying raw read depth are aggregated based on one of three approaches: (i)
unstitched (peaks and their underlying raw read depth); (ii) fixed stitching, in which peaks within
a certain distance of each other [typically a 12.5-kb window (10)] are merged together to represent
one broad region of interest; or (iii) dynamic stitching, in which a window is slowly increased
from 0 kb (unstitched) to a maximum of 15 kb, in adjustable increments of 500 bp, and the number
of enhancer clusters identified per window is recorded. The rate of growth (the first derivative)
of this growing window is computed, and the point at which the rate of growth of called enhancers decreases (the inflection point) is used to merge nearby peaks together. (See SI Materials and
Methods for further discussion of the rationale for using these three approaches in various facets
of our analyses).
The Super-Enhancer Landscapes of IELs and Circulating T Cells, Independent of
Colonization Status.
We identified putative enhancers shared by the two types of purified IEL populations (αβ+ and γδ+
T cells) and those shared by the two types of purified peripheral lymphocyte populations (CD4+
and CD8+ T cells), independent of colonization status (GF ∪ CONV-R ∪ CONV-D; Fig. S1B).
Data generated from these purified cell populations were highly reproducible (Fig. S1C). The
different enhancer populations were reflected in a hierarchical clustering that clearly stratified by
cell type (Fig. S3A). We divided these putative enhancers into two groups: a set of “traditional”
enhancers, and a subpopulation of super-enhancers. Super-enhancers are a subclass of enhancers that are stronger (more occupied by transcriptional activators) and can span longer regions of
DNA than traditional enhancers (9, 10). Super-enhancers can drive cell lineagespecific functions
and play critical roles in disease pathogenesis (11, 12). We identified super-enhancers by first combining adjacent peaks within a 12.5-kb window (the fixed stitching approach described above),
ranking and graphing these merged enhancers by their normalized read depth (ATAC-seq signal),
and discriminating traditional enhancers from super-enhancers by determining where the slope of
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a tangent line fitted to their graph reached one (10). The resulting graph fit an exponential curve
in which the largest ATAC-seq signal occurred at a small minority of enhancers (Fig. S3B and
Dataset S2).
Super-enhancers, although comprising <5% of the aggregate IEL enhancer population
(4.4% in TCR αβ+ IELs and 4.9% in TCR γδ+ IELs), accounted for a disproportionate share of the
aggregate ATAC-seq signal (35%) compared with the traditional enhancer group; super-enhancers
also spanned broader regions of the genome than did traditional enhancers [29,447 ± 440 vs. 3,988
± 31 bp (mean ± SEM)]. These patterns fit well with other studies, which show similar distributions
of signal and enhancer width when applying ATAC-seq and complementary techniques, including
p300 and Mediator ChIP-seq, in different tissues (9, 12, 13). The colonization-independent superenhancer populations in TCR αβ+ and TCR γδ+ IELs were highly similar, with a Jaccard similarity
index of 83% (Fig. S3A). The top-ranked super-enhancer in both IEL populations is adjacent to
Prkch (Fig. S3B), a nonclassical Ca2+-insensitive η-type PKC that promotes T-cell activation and
cytoskeletal polarization (14, 15).
Applying the same analytic approach to peripheral circulating T cells revealed that superenhancers comprised 5.7% of the population but 37.7% of the aggregate ATAC-seq signal [values
comparable to those reported in mice and humans (9, 12, 13, 16)]. The super-enhancer associated
with Bach2 (basic leucine zipper transcription factor 2) produced the top-ranked ATAC-seq signal
in CD4+ T cells (Fig. S3 C and D and Dataset S2). This finding was notable, given a previous report that used p300 ChIP-seq to identify Bach2 as the strongest super-enhancer in CD4+ T cells,
and as a critical negative regulator of pathogenic T-cell effector differentiation and as a positive
regulator of regulatory T-cell induction (12, 17).
We performed a network analysis of genes located in the proximity of the top 250 superenhancers (ranked by ATAC-seq signal) from the combined population of TCR αβ+ and TCR
γδ+ IELs, independent of colonization status, using GeNets (SI Materials and Methods). GeNets
defines “communities” as sets of genes with a high degree of connectivity based on a random for18

est classifier trained on datasets of established protein–protein interactions. This network analysis
clustered super-enhancer–associated genes into eight distinct communities that display functions
that are lineage-defining components of IELs (e.g., TCR signaling; see Dataset S3 for a complete
list of components and their assigned functions). GeNets also identified significant connections
among these eight communities (Fig. S4).
Contrasting the Chromatin Landscapes of TCR αβ+ vs. TCR γδ+ IELs, Independent of
Colonization Status.
We applied a negative-binomial model to the dataset of enhancers described above to identify
lineage-specific features of the TCR αβ+ and TCR γδ+ chromatin landscapes, independent of colonization status. We were wary of applying this model only to the collection of peaks stitched within
the 12.5-kb window initially applied to the datasets: Although appropriate for defining strong
super-enhancers, this fixed window could, potentially, drown out signals from differentially accessible but narrower enhancer regions. Understanding that the width of enhancers can vary across
different cell types and tissues, we used the dynamic stitching approach to merge peaks, with the
goal of adapting to variable enhancer widths (Fig. S5A). Applying a binomial model to these dynamically stitched peaks yielded 4,704 predicted enhancers demonstrating differential accessibility (13.2% of all dynamically stitched IEL enhancers at P < 0.05 by Benjamini– Hochberg-adjusted
Wald test). Filtering to a more stringent cutoff (P < 5 × 10−5 by Benjamini–Hochberg-adjusted
Wald test) yielded 598 predicted enhancers with increased accessibility in TCR αβ+ compared
with TCR γδ+ IELs and 295 with increased accessibility in TCR γδ+ vs. TCR αβ+ IELs (Fig. S5B).
(For all differentially accessible enhancers observed at P < 0.05, see Dataset S4 A and B. For an
analysis in peripheral T cells, see Dataset S4 C and D).
We performed a pathway analysis on the collection of statistically significant enhancers
using GREAT (Genomic Regions Enrichment of Annotations Tool) (18), first focusing on regions
with increased accessibility in the TCR αβ+ IEL population and comparing them to the set of all
enhancers in both IEL lineages independent of colonization status. We used GREAT because it can
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consider multiple genes in proximity to a given enhancer when calculating pathway enrichment
(as opposed to a GeNets-based analysis, which incorporates only the most proximal gene). The
results revealed significant enrichment (P < 0.05; hypergeometric test) of enhancer-adjacent genes
belonging to numerous pathways in the MSigDB (Molecular Signatures Database) encompassing
Reactome, KEGG (Kyoto Encyclopedia of Genes and Genomes), other metabolic databases, and
GO (Gene Ontology). These pathways are rank ordered based on their statistical significance in
Dataset S5A (see SI Results for further discussion).
Chromatin Landscape in TCR αβ+ IELs from CONV-R vs. GF Mice.
Comparing the TCR αβ+ IEL chromatin landscape in CONV-R vs. GF animals using our dynamic
stitching approach and binomial model yielded 7,137 predicted enhancers with colonization-associated differences in their accessibility (P < 0.05, Benjamini–Hochberg-adjusted Wald test) with
1,362 surviving more stringent filtering (P < 5 × 10−5 ). Of these, 497 were significantly more accessible in TCR αβ+ IELs purified from CONV-R mice than in TCR αβ+ IELs from GF animals,
and 865 enhancers met this more stringent cutoff for increased accessibility in GF animals (Fig. S5
C and E and Dataset S8A). Fig. 1A shows that IEL enhancers cluster first by colonization history
and then by cell type, in contrast to circulating peripheral T cells in which cell type has a larger
discriminatory effect.
We used GeNets to identify potential interactions between genes located near colonizationassociated enhancers. The resulting GeNets communities were enriched for (i) members of the
PDGF signaling pathway whose associated enhancers were more accessible in TCR αβ+ IELs
from GF mice (community members Grb10, Pik3cb, Pik3r2, Ptpn11, and Ptprj; see Dataset S9A)
and (ii) members of JAK-STAT [community members Cblb (Cbl proto-oncogene B), Il12rb2 (IL12 receptor β2), Il23r (IL-23 receptor), Il7r (IL-7 receptor), and Prlr (Prolactin receptor)] and TCR
(community members Cblb, Nck2, and Prkcq) signaling, and leukocyte transendothelial migration
[Cxcr4 (C-X-C chemokine receptor type 4), Itga4 (Integrin subunit alpha 4), and Ptk2 (protein
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tyrosine kinase 2)] pathways whose associated enhancers were more accessible in CONV-R TCR
αβ+ IELs (Fig. 1B and Dataset S9B).
A GREAT-based analysis of all enhancers with statistically significant (P < 0.05) increased
accessibility in CONV-R vs. GF TCR αβ+ IELs disclosed significant overrepresentation of pathways involved in bile acid metabolism, propionate metabolism, and sulfur amino acid metabolism
(Dataset S10A). Members of the microbiota direct a complex set of metabolic transformations of
bile acids (19) which can influence intestinal inflammation through multiple mechanisms. Propionate, a product of microbial fermentation of dietary glycans, is a histone-deacetylase inhibitor (20)
and has immunomodulatory effects in the gut (21). Sulfur-containing amino acids are coupled to
methyl donor availability via their interconversion to S-adenosylmethionine. Moreover, gut inflammation induces elaboration of homocysteine from monocytes in the lamina propria; increased
levels of this amino acid are associated with inflammatory bowel diseases (22).
Several genes in the GO “Regulation of lymphocyte activation” pathway with well-described roles in the accumulation of IELs were associated with enhancers having greater chromatin
accessibility following colonization. These include ahr, encoding the aryl hydrocarbon receptor
(AhR), which controls accumulation of CD8αα+ TCRβ+ IELs (23); id2, which is required for accumulation of CD8αβ+ IELs (24); il15ra (IL15 receptor α), which encodes a component of the
IL-15 receptor; and il7r, which specifies a component of the IL-7 receptor. IL-15 and IL-7 are
important cytokines controlling the accumulation and function of CD8αα+ IELs (25– 28). Additionally, members of two pathways, KEGG “Cell adhesion molecules” (35 genes) and KEGG
“ECM–receptor interaction” (25 genes), were also associated with enhancers exhibiting increased
accessibility in CONV-R compared to GF TCR αβ+ IELs (Dataset S10A); changes in chromatin
state affecting enhancers positioned next to genes in these pathways may reflect broad changes in
TCR αβ+ interactions with the intestinal epithelium upon colonization.
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Chromatin Landscape in TCR γδ+ IELs from CONV-R vs. GF Mice.
We identified 4,579 differentially accessible enhancers in TCR γδ+ IELs recovered from CONV-R
and from GF animals (P < 0.05, Benjamini–Hochberg-adjusted Wald test). Filtering these datasets
to P < 5 × 10−5 yielded 165 putative enhancers with significantly increased accessibility and 511
with significantly decreased accessibility (Fig. S5D and Dataset S8B). GeNets predicted a number
of communities of interacting genes positioned near topranked colonization-responsive enhancers, including genes involved in TGF-β receptor signaling and adherens junction pathways; their
associated enhancers exhibited increased accessibility in CONV-R animals (Dataset S9 C and D).
GREAT-based analysis using the entire collection of statistically significantly enhancers
with colonization-associated increases in their accessibility disclosed a significant enrichment of
genes in KEGG “Cell adhesion molecules” and “ECM–receptor rinteractions” pathways (Dataset
S10D). A similar enrichment of these two pathways was also observed in TCR αβ+ IELs (Dataset
S10A) and operationally defines a shared response of these two IEL lineages to the presence of a
gut microbiota. Enhancers neighboring several genes in GO categories involved in leukocyte and
lymphocyte activation and cytokine interactions also exhibited significant increases in accessibility with colonization in TCR γδ+ IELs (Dataset S10D); these genes include Cd28, Cxcr4, Il15ra,
Il2, Il10, Cd40lg, and Ccr7, some of which are associated with the activation of T cells and have
been implicated in shaping the IEL compartment. As noted above, IL-15 responsiveness has been
shown to be key for the accumulation of CD8αα+ TCRβ+ cells and also for TCR γδ+ cells (25–28).
ion of cytokine production” were associated with enhancers with decreased chromatin accessibility in TCR γδ+ IELs from CONV-R compared to TCR γδ+ IELs from GF mice; they
include tigit, a cell-intrinsic (29) and cell-extrinsic (30) inhibitor of effector T-cell function, Il10,
which encodes an anti-inflammatory cytokine (31), and furin, which regulates levels of effector
T-cell activation (32). The reduced accessibility of enhancers associated with these genes may reflect a homeostatic response to the increased activation of these cells upon exposure to microbial
stimuli that is designed to maintain the delicate balance between pathogenic and protective immu22

nity in the intestine. The top-ranked KEGG pathways composed of genes proximal to enhancers
that manifest significant decreases in their accessibility in CONV-R TCR γδ+ IELs as compared
with GF TCR γδ+ IELs are presented in Dataset S10E (e.g., 23 genes involved in KEGG “Inositol
phosphate metabolism”).
Comparing CD4+ and CD8+ T cells isolated from the peripheral circulation of GF and
CONV-R mice revealed markedly fewer differentially accessible enhancers than in the IEL populations (n = 35 and 26 in the CD4+ and CD8+ populations, respectively; P < 0.05 Benjamini–
Hochberg-adjusted Wald test; Dataset S8 C and D). Five enhancer-associated genes (Cblb, Ica1l,
Lrrc8c, Mid1, and Nme7) were shared between the two T-cell populations. All demonstrated increased accessibility in both lineages in CONV-R compared with GF mice. Many of the differentially accessible peripheral T-cell enhancers were also responsive to colonization in the IEL
lineages (31% of CD4+ and 46% of CD8+ T-cell enhancers, respectively; compare Dataset S8 A
and B with Dataset S8 C and D).
Analysis of Enhancers in IELs Purified from CONV-D Mice.
We expanded our analyses to the group of CONV-D mice that had been reared under GF conditions during the first three postnatal weeks and then were colonized with the cecal microbiota of
an 8-wk-old C57BL/6J CONV-R animal and were killed 5 wk later (see Fig. S6 for the results
of a bacterial 16S rRNA-based analysis of fecal samples collected at the time mice were killed).
We binned enhancers based on differences in their accessibility in IELs recovered from CONV-D
mice compared with IELs recovered from GF mice and in IELs recovered from CONV-D mice
compared with IELs recovered from CONV-R mice. A set of microbiota-responsive enhancers was
identified; these were defined as regions in CONV-D mice whose accessibility was significantly
different compared with regions in GF mice but was not significantly different from regions in
CONV-R animals.
The top-ranked microbiota-responsive enhancers in TCR αβ+ IELs (n = 172) were located
in the neighborhood of genes with broad roles in transcriptional regulation and cell growth, in23

cluding Tshz1, Celf2, and Nav2 (Dataset S11A). Given the limited size of the dataset of these enhancers, we applied an alternative approach to identify pathways whose genes are associated with
microbiota-responsive enhancers. Ingenuity Pathway Analysis (IPA) (SI Materials and Methods)
revealed that the top-ranked pathway in TCR αβ+ IELs is involved in the late stages of heparan
sulfate synthesis. In the case of TCR γδ+ IELs, the top-ranked pathways associated with enhancers
classified as microbiota-responsive (n = 141) were linked to sphingosine-1-phosphate (S1P) and
ceramide signaling (Dataset S11B). Enhancers located near S1pr1, S1pr2, and S1pr3 contributed
to these enrichments. One role of S1P is to direct the trafficking of IELs from the thymus to the intestine; global hematopoietic deficiency of S1pr1 reduces the ability of TCR γδ+ cells to populate
the small intestine (33). The representation of these pathways among the microbiota-responsive
group of enhancers may reflect a component of the codevelopment of the functional state of TCR
γδ+ IELs and the gut microbial community during an important malleable stage of their relationship.
Transcription Factor Regulatory Circuitry.
Understanding that the accessibility of cis-regulatory enhancer elements is mediated by the recruitment of transcription factors (TFs) and that TFs and enhancers interact in complex feedback loops,
we performed a de novo reconstruction of TF regulatory circuitry (SI Materials and Methods)
(34). In any cell type, a small number of the ∼500 expressed TFs critically define cell identity;

these master TFs are often associated with super-enhancer elements (35). To investigate the effects of the gut microbiota on the TF circuitry regulating cell identity, we modeled TF–enhancer
interactions (TFi ) for all TFs associated with dynamically stitched super-enhancers. For each TFi
, we computed the inward connectivity (“IN degree”) to determine how the TFi is regulated by
itself and by other TFs at its own enhancer(s). We then computed the outward connectivity (“OUT
degree”) to quantify how a TFi regulates enhancers of genes encoding other TFs (Fig. 2A). We
predicted enriched TF binding sites within ATAC-seq–accessible regions for all super-enhancers
located proximal to TFs in TCR αβ+ and TCR γδ+ IELs from GF and CONV-R mice and then
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computed the IN and OUT degrees for these super-enhancer–associated TFs. Super-enhancer–
associated TFs were included in subsequent analyses if their unit-normalized total degree (IN +
OUT) was greater than 0.75, indicating that the TF is in the top quartile of regulatory influence.
For each IEL population, the interactions of all super-enhancer–associated TFs with a normalized
total degree >0.75 are shown in Fig. 2B.
There was a significant concordance for TF regulatory connectivity across IELs, independent of colonization status, at 24 TF binding-site motifs (Dataset S12). Both TCR αβ+ and γδ+ IELs
were enriched for a number of TF motifs, including ETS1/ETS2- binding sites. The ETS family
plays a crucial role in T-cell development and can induce chromatin remodeling during early T-cell
differentiation (36). There was also strong enrichment for RUNX1 and RUNX3; members of this
family of TFs have been identified as regulators of critical TCR αβ+ and TCR γδ+ pathways (37,
38). A recent assessment of chromatin state in innate lymphoid cells also demonstrated that highly
active enhancers show enrichment for ETS and RUNX motifs, suggesting potential commonality
in developmental and functional pathways within IEL populations of the small intestine (39). Ahr,
encoding the aryl hydrocarbon receptor, also was found to have high regulatory connectivity in
both GF and CONV-R groups. This observation aligns well with its defined roles in TCR γδ+ cells
and in CD8αα+ TCRβ+ accumulation, and with our observation that this receptor is colonizationresponsive in TCR αβ+ IELs (23).
We also identified a regulatory network of TF motifs that were sensitive to colonization
status. We limited our comparisons to GFvs. CONV-R IELs because a much more limited set of
differentially accessible enhancers was identified in CONV-D IELs after applying our high-stringency cutoff. Ten TF binding-site motifs exhibited a high total degree of regulatory connectivity
in both TCR αβ+ and TCR γδ+ IELs isolated from GF mice compared with those isolated from
CONV-R mice (Fig. 2C and Dataset S12). They included the TFs IRF1 and STAT3, which have
been identified as critical regulators of IEL maturation and the antiapoptotic activity of IL-15 in
IELs (40). Although the multiple STAT TFs identified in the circuitry share similar binding motifs,
and thus similar OUT degrees, we are able to infer differences in their regulation by examining
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their IN degree, which predicts how the genes encoding the TFs themselves are regulated. Additionally, for the Stat3 gene, there is an increase in enhancer accessibility in TCR αβ+ IELs from
GF mice compared with TCR αβ+ IELs from CONV-R mice that is not present for Stat1 (Fig. S7).
The Stat3 enhancer contains large numbers of predicted binding sites for the JUN/FOS and MAFK
bZIP TFs that are not present in the Stat1 gene (Fig. S7). Taken together, these data suggest an
increase in the regulatory activity of Stat3 in IELs purified from GF mice compared with those
from CONV-R animals.
In the reciprocal comparison, three TF binding-site motifs manifested a high degree of
regulatory connectivity in TCR αβ+ and TCR γδ+ IELs recovered from CONV-R mice compared
with those recovered from GF animals: GATA3, a critical regulator of T-cell function and master
TF for Th2 helper cells (41); KLF3, which has broad regulatory roles, including intestinal IgA
production; and REL, which plays a key role in driving both Th1 (42) and Th17 (43, 44) responses
to pathogens (Dataset S12 C and D). These observations suggest a microbiota-regulated role for
these TFs in the establishment and maturation of these IEL lineages.
Discussion
The location and cellular features of IELs are well described. However, the molecular mechanisms underlying their capacity to exert a rapid and diverse set of effector functions in response to
stimulation have been largely undefined. One key stimulus occurs during colonization of the gut
with a microbiota. Here, we used ATAC-seq and the RIESLING suite of software tools we developed to conduct a genome-wide search for enhancers and pathways enriched in genes adjacent to
these enhancers. Our results demonstrate that this approach can clearly distinguish and classify
cis-regulatory landscapes of distinct immune lineages. We find that gut colonization status does
not fundamentally alter lineage-specific cis-regulatory landscapes but rather induces quantitative
changes in the accessibility of these preestablished enhancer elements (Fig. S5E). Our findings differ from a previous DNase-seq study in which the authors concluded that the transcriptional state
was modified by colonization with a gut microbiota from a specified pathogen-free mouse donor in
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a manner that appeared to be independent of chromatin remodeling (2). That study used a heterogeneous population of intestinal epithelial cells. One possible explanation for the differences in our
conclusions is that signals from enhancers with differential accessibility may be drowned out in a
highly heterogeneous population of starting cells. We were able to identify quantitative differences
in chromatin accessibility in purified cell lineages using ATAC-seq, which requires much smaller
numbers of cells than DNase-seq. Our findings also are consistent with the quantitative changes
observed in a recently reported iChIPIVT analysis of innate lymphoid cells harvested from CONVR animals that had or had not been treated with antibiotics (see the Introduction and ref. 4).
It is tempting to speculate that gut epithelial cell lineages that are in direct contact with
the microbiota are poised to exploit a preexisting chromatin landscape in ways that allow them to
respond rapidly to microbial stimulation. Although increases in chromatin accessibility correlate
with transcriptional activity, these measurements are limited in their ability to characterize more
complex modulations of the chromatin state. For instance, enhancers can be poised or active (45),
and the recruitment of chromatin regulators at preexisting accessible sites can dramatically modulate transcriptional responses (46–48). Nonresponsive enhancers, which fail to exhibit alterations
in chromatin accessibility after delayed exposure to a microbiota, could reflect (i) the existence
of a critical developmental window beyond which chromatin modification is not possible or is
unlikely; (ii) the need for a minimal length of time of microbial exposure, irrespective of when the
microbiota is first introduced, that was not satisfied under our experimental conditions (5 wk of
exposure starting at the end of postnatal week 3); or (iii) differences in the structural and functional
configuration of the microbiota that we observed between CONV-R and CONV-D animals.
Our results provide an estimation of the magnitude of the gut microbiota’s influence on
the epigenetic state of IELs and define the enhancers and pathways impacted by colonization.
Future efforts to understand how the functional epigenetic states of IELs are modified by specific
members of the gut microbiota, the nature of the diet being consumed, and the period in postnatal
development when these cells first encounter gut microbes will be important to develop a mechanistic understanding of how these interactions contribute to protective immunity. These questions
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are relevant not only to normal host development but also to disorders in which various facets of
development are impaired, including in children with undernutrition who have disrupted maturation of their gut microbiota (49, 50).
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Materials and methods
Mouse experiments were performed using protocols approved by the Washington University Animal Studies Committee. A detailed description of protocols used for (i) gnotobiotic animal husbandry, (ii) 16S rRNA-based characterization of bacterial taxa present in the fecal microbiota of
CONV-R and CONV-D mice, (iii) purification of small intestinal IELs and circulating CD4/CD8+
T cells, and (iv) ATAC-seq (including transposition and sequencing protocols; the architecture of
the RIESLING computational pipeline; the approach for identifying enhancers that exhibit significant differences in their accessibility in the different immune cell lineages as a function of
colonization status; data normalization; pathway analyses; and characterization of TF regulatory
circuitry) is provided in SI Materials and Methods.
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Figure legends
Fig. 1.
The effects of colonization on enhancer populations in IELs. (A) Unsupervised clustering of dynamically stitched enhancers identified in all four immune cell populations purified from GF,
CONV-R, and CONV-D mice demonstrates that these enhancers not only stratify by cell type but
also stratify TCR αβ+ and TCR γδ+ IEL lineages based on their history of microbial exposure. The
areas boxed in red show that IELs from GF mice or from CONV-D mice cluster separately from
IELs recovered from CONV-R mice exposed to microbes beginning at birth. Jaccard distance metric scores between enhancer regions from a given cell type are shown in blue shading where a value of 1.0 reflects complete overlap. Clustering was performed on the largest dynamically stitched
enhancers using the super-enhancer cutoffs described in the text. (B) Heatmap demonstrating the
ATAC-seq signal from components of the “JAK-STAT,” and “leukocyte transendothelial migration” signaling pathways whose enhancers demonstrate increased accessibility in CONV-R TCR
αβ+ IELs. These members were identified as overrepresented in a GeNets-based analysis (Dataset
S9B).
Fig. 2.
Analysis of colonization-associated TF circuitry. (A) Overview of IN/OUT degree. In this example, the IN degree is the number of TFs (TF-A, TF-B, and TF-C) that regulate the expression of
a gene encoding a TF (TF-A). The OUT degree is the number of enhancers (E1, E2, E3, E4) that
contain binding-site motifs for TF-A. (B) Regulatory connectivity of enhancer-associated TFs in
TCR αβ+ and TCR γδ+ IELs purified from the indicated groups of mice. For each IEL population,
the interactions of all enhancer-associated TFs with a normalized total (IN+OUT) degree >0.75
are shown. TFs with a normalized total degree of at least 0.75 in either GF or CONV-R cells are
highlighted in red or blue, respectively. (C) The total IN+OUT degree for all enhancer-associated
TFs with a normalized total degree >0.75 are hierarchically clustered using a Euclidean distance
metric allowing categorization of groups of TFs with similar regulatory patterns. TFs are color
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coded by their degree of connectivity in each colonization group: blue- and red-colored TFs demonstrated a high degree of connectivity in CONV-R and GF IELs, respectively. TFs colored black
displayed high connectivity in both IEL populations, and those in brown displayed a mixed pattern
of connectivity.
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Dataset S1. Overview of samples and ATAC-seq datasets
A summary of all samples in the study (including read counts), stratified by cell type and colonization status.
Dataset S2. Super-enhancers identified in all populations, independent of colonization status, rank
ordered by signal intensity This dataset encompasses all the super-enhancers presented in Fig.
S1B. Super-enhancers were identified using the RIESLING pipeline. For each predicted superenhancer, chromosome location, predicted boundaries, signal intensity, and most proximal gene
(independent of orientation) are listed. (A) TCR αβ+ IELs. (B) TCR γδ+ IELs. (C) Both IEL
populations. (D) CD4+ T cells only. (E) CD8+ T cells only. (F) Both T-cell populations (CD4+ U
CD8+).
Dataset S3. Pathway analysis within the GeNets-predicted communities from the top IEL superenhancers
The GeNets analysis identified eight predicted communities of interconnected super-enhancers
(applied to the top 250 super-enhancers from the combined population of TCR αβ+ and TCR γδ+
IELs independent of host colonization status). Pathway analyses applied to these communities
identified a number of enriched pathways, described here by community.
Dataset S4. Lineage-specific enhancers independent of colonization status
Differentially accessible enhancers were identified using binomial modeling via DESeq2. Statistical significance, based on a Benjamini–Hochberg-adjusted Wald test, reflects the consistency
of differences in enhancer accessibility in each cell lineage across all animals regardless of their
membership in the GF, CONVR, or CONV-D groups (colonization independent). (A) Enhancers
more accessible in the TCR αβ+ IELs, rank ordered based on the statistical significance. (B) Enhancers more accessible in the TCR γδ+ IELs. (C) Enhancers more accessible in CD4+ T cells. (D)
Enhancers more accessible in CD8+ T cells.
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Dataset S5. Pathway analysis of lineage-specific differentially accessible enhancers independent
of colonization status
Pathway analyses were applied to genes adjacent to enhancers described in Dataset S4. Analyses
used GO Molecular Function, Biological Process, and Cellular Component and MSigDB Pathways. Pathways are rank ordered based on the statistical significance of their enrichment (hypergeometric and binomial tests). (A–D) Pathways with increased accessibility in TCR αβ+ IELs (A),
TCR γδ+ IELs (B), CD4+ T cells (C), or CD8+ T cells (D).
Dataset S6. Pathway analysis of genes near predicted enhancers in IEL populations, independent
of colonization status
Pathway analyses were performed comparing genes proximal to identified super-enhancers with
the whole mouse genome as a background and comparing genes proximal to traditional enhancers with the whole mouse genome. A third comparison, designed to highlight potential functional
differences between super-enhancers and traditional enhancers, involved a direct comparison of
genes proximal to super-enhancers with genes proximal to all enhancers [i.e., the set of traditional
and super-enhancers instead of the mouse genome (mm10)]. Pathways from GO and MSigDB are
rank ordered based on the statistical significance of their enrichment (hypergeometric and binomial tests). (A) IEL (combined TCR αβ+ and γδ+) super-enhancers vs. mm10. (B) IEL traditional
enhancers vs. mm10. (C) IEL super-enhancers vs. traditional enhancers. (D) TCR αβ+ super-enhancers vs. mm10. (E) TCR γδ+ super-enhancers vs. mm10. (F) TCR αβ+ traditional enhancers vs.
mm10. (G) TCR γδ+ traditional enhancers vs. mm10. (H) TCR αβ+ super-enhancers vs. traditional
enhancers. (I) TCR γδ+ super-enhancers vs. traditional enhancers.
Dataset S7. Pathway analysis of genes near predicted enhancers in CD4+ and CD8+ T-cell populations, independent of colonization status
Pathway analyses were performed as described in Dataset S6. Pathways are rank ordered based
on the statistical significance of their enrichment (using hypergeometric and binomial tests). (A)
Peripheral T-cell (combined CD4+ and CD8+) super-enhancers vs. mm10. (B) Peripheral T-cell
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traditional enhancers vs. mm10. (C) Peripheral T-cell super-enhancers vs. traditional enhancers.
(D) CD4+ super-enhancers vs. mm10. (E) CD8+ super-enhancers vs. mm10. (F) CD4+ traditional
enhancers vs. mm10. (G) CD8+ traditional enhancers vs. mm10. (H) CD4+ super-enhancers vs.
traditional enhancers. (I) CD8+ super-enhancers vs. traditional enhancers.
Dataset S8. Differentially accessible regions of chromatin identified comparing GF to CONV-R
mice
Included here are statistically significant (P < 0.05, Benjamini–Hochberg-adjusted Wald test) differentially accessible enhancers and associated genomic features identified in TCR αβ+ IELs (A),
TCR γδ+ IELs (B), CD4+ T cells (C), and CD8+ T cells (D).
Dataset S9. Pathway analysis within the GeNets-predicted communities from the genes adjacent to
differentially accessible enhancers identified in IELs purified from CONV-R vs. GF mice
Also included are inferred candidate genes (and their pathways) that displayed connectivity and
known interactions similar to those we observed. (A) Increased accessibility in GF TCR αβ+ IELs.
(B) Increased accessibility in CONV-R TCR αβ+ IELs. (C) Increased accessibility in GF TCR γδ+
IELs. (D) Increased accessibility in CONV-R TCR γδ+ IELs.
Dataset S10. GREAT analysis applied to differentially accessible enhancers and their adjacent
genes identified in IELs from CONV-R vs. GF mice
Included are statistically significant results (hypergeometric test P < 0.05) from the GO consortium
and MSigDB. (A–C) Within TCR αβ+ IELs, pathways enriched for genes proximal to enhancers
demonstrating increased accessibility (A) and decreased accessibility (B), and independent of accessibility (C). (D–F) Within TCR γδ+ IELs, pathways enriched for genes proximal to enhancers
with increased accessibility (D), decreased accessibility (E), and independent of accessibility (F).

42

Dataset S11. Enhancers classified as microbiota-responsive, based on whether their accessibility
changes in the GF vs. CONV-D and CONV-R groups
Included are statistically significant (P < 0.05, Benjamini–Hochberg-adjusted Wald test) differentially accessible enhancers and their most adjacent genes, classified as microbiota-responsive in
TCR αβ+ IELs (A) and in TCR γδ+ IELs (B). Fold-changes and statistics reflect the comparison
between GF vs. CONV-R groups.
Dataset S12. Analysis of TF circuitry in GF and CONV-R IEL enhancers
TF circuitry based on IN/OUT degree was analyzed using dynamically stitched enhancers. TFs
shown in boldface have a high degree of connectivity and also are displayed in Fig. 2B. Those
with an asterisk are also colonization specific. (A) GF TCR αβ+ IELs. (B) GF TCR γδ+ IELs. (C)
CONV-R TCR αβ+ IELs. (D) CONV-R TCR γδ+ IELs.
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Supplemental materials
SI Results
We also contrasted the chromatin landscapes of TCR αβ+ vs. TCR γδ+ IELs, independent of colonization status. Our GREAT-based analysis revealed that the most statistically significant enrichment for MSigDB pathways in TCR αβ+ IELs was “Glycosaminoglycan biosynthesis– heparin
sulfate” (10 genes) (Dataset S5A). Heparan sulfate-binding proteins have been reported to have
antimicrobial effects in both gut and lung (51). The two most significantly enriched GO Molecular Functions were “UDP-xylosyltransferase activity” and “Protein xylosyltransferase activity,”
which were driven by multiple enhancers around three genes (Gxylt2, Xylt1, and Xylt2) and which
contribute to glycosaminoglycan biosynthesis, including heparan sulfate. T cells with a deficiency
in heparan sulfate biosynthetic enzymes are hyperresponsive to low-level activation (52).
The most statistically significant MSigDB pathway in TCR γδ+ IELs was N-glycan biosynthesis (based on eight distinct genes adjacent to enhancers), including a number of mannosidases (Dataset S5B). N-glycosylation and mannosidase activity are important for T-cell migration
in an allograft model (53) and serve an important inhibitory role in preventing T-cell activation
(54). The most statistically significant GO Molecular Function was “Receptor signaling protein
tyrosine kinase activity,” driven by multiple enhancers around three genes, Erbb4, Kit, and Syk; the
latter two genes have been identified as factors affecting TCR γδ+ survival in the intestine (55, 56).
The rank order of pathway enrichment in these two IEL lineages differs from that observed
in CD4+ and CD8+ T cells (compare Dataset S5 C and D with Dataset S5 A and B). For parallel
GREAT analyses comparing enhancers with the whole mouse genome (mm10), see Datasets S6
(IELs) and S7 (peripheral T cells).
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SI Materials and methods
Animals. Adult (8- to-10-wk-old) GF male C57BL/6J mice were maintained either in flexible gnotobiotic isolators (for the GF and CONV-D groups; Class Biologically Clean Ltd.) or in a specific
pathogen-free barrier facility (CONV-R group), under a strict 12-h light cycle (light on at 0600, off
at 1800). Pups were weaned onto a sterilized low-fat, plant polysaccharide-rich chow (B&K Universal; Product 7378000) that was provided ad libitum. All mice were housed in cages containing
indigestible cellulosic bedding (Aspen wood shavings; NEPCO). CONV-D mice were colonized at
3 wks of age by gavage of cecal contents harvested from an adult male CONV-R C57BL/6J donor.
Gavage was performed using 200 μL of a slurry of cecal contents homogenized in 5 mL sterile
PBS, with the remaining mixture spread on fur.
All mice were killed in the morning, and all four immune cell populations were isolated in
parallel from up to four mice simultaneously. Where possible, subsets of mice from different treatment groups (e.g., two GF mice and two CONV-R mice) were killed at the same time to reduce
technical and day-to-day biases associated with the purification of cell populations and preparation
of nuclear DNA for ATAC-seq.
Bacterial 16S rRNA Analysis.
16S rRNA PCR was performed on fecal samples collected from CONV-R, CONV-D, and (as a
quality control) GF mice. Fecal samples were collected at the time mice were killed, frozen immediately in liquid nitrogen, and stored at −80 °C until analysis. DNA was isolated from samples by
bead beating and subsequent extraction in 210 μL of 20% SDS, 500 μL buffer A (200 mM NaCl,
200 mM Trizma base, 20 mM EDTA), and 500 μL phenol:chloroform:isoamyl alcohol (at a ratio of
25:24:1). Isolated DNA was purified using QIAquick columns (Qiagen) followed by elution in 70
μL Tris-EDTA. Purified DNA was quantified using the Quant-iT dsDNA assay (broad range; Invitrogen) and was normalized to 1 ng/mL. PCR was performed using phased, barcoded primers, and
amplicons were generated from variable region 4 (V4) of bacterial 16S rRNA genes. Fecal samples
from the GF mice failed to produce detectable levels of amplicons. Amplicons were subsequently
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sequenced from CONV-D and CONV-R mice using an Illumina MiSeq (paired-end 250-nt reads).
Reads were de-multiplexed and clustered based on 97% sequence identity to the Greengenes database for operational taxonomic units (OTUs) (57). Novel OTUs from the remaining sequences
were grouped using the UCLUST method [using QIIME version 1.9 (58)], and taxonomy was assigned using RDP 2.11 trained on a custom database aggregating the Greengenes “Isolated named
strains 16s collection” and the National Center for Biotechnology Information (NCBI) taxonomy
database.
A phylogenetic tree of the OTUs’ representative V4-16S rRNA sequences was constructed
and used to calculate Faith’s phylogenetic diversity as well as weighted and unweighted UniFrac
distances. The number of observed OTUs was also calculated for each sample (rarefied to 5,000
reads), and binary Jaccard dissimilarities were calculated for each pair of samples. ANOVAs were
used to test for differences in the means of alpha-diversity metrics (phylogenetic diversity, Shannon’s diversity index, observed OTUs) between CONV-D and CONV-R mice, and permutational
multivariate analyses of variance (PERMANOVA) were used to test for differences in community
structure (unweighted UniFrac distances, weighted UniFrac distances, and binary Jaccard dissimilarities). Indicator species analysis was used to identify specific OTUs that were more strongly
associated with CONV-D or CONV-R mice. Before this analysis, OTUs that were not detected
in at least three CONV-D or three CONV-R mice or that had mean relative abundances less than
0.1% in both groups were removed from the dataset. Significance was assessed by permutation
tests using 10,000 randomizations, and P values were corrected for false discovery using the Benjamini–Hochberg method.
Isolation of cell populations.
Small intestinal IELs. When mice were killed, the small intestines were excised, placed in HBSS
lacking calcium and magnesium at 4 °C, rinsed gently with ice-cold HBSS to remove luminal
contents, dissected along their cephalocaudal axis, and minced into 3- to 5-mm fragments. These
fragments were agitated gently for 15 min (37 °C) in 15 mL of HBSS containing EDTA (5 mM),
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and the suspension was passed through a sterile 100-μm mesh nylon filter (Falcon/Corning; no.
352360). This step was repeated, and the filtrates were combined and centrifuged for 5 min at 500
× g. Supernatants were discarded, and cell pellets were resuspended in 10 mL of 40% Percoll/
RPMI (RPMI Medium 1640, Gibco; Percoll no.17-0891-01, GE Life Sciences). The suspension
was subsequently layered over 5 mL of 80% Percoll/RPMI, and the material was centrifuged for
20 min at 650 × g (18 °C) with the brake off. Cells at the resulting 40%/80% Percoll interface were
collected, washed once with 50 mL of RPMI, and isolated again by centrifugation (5 min at 500 ×
g). The resulting supernatant was discarded, and cell pellets were transferred to a round-bottomed
96-well plate for Fc receptor blocking and antibody staining as described below.
Circulating CD4/CD8+ T cells. CD4+ and CD8+ T cells were isolated by collecting ∼500

μL of whole blood at the time mice were killed in EDTA-containing tubes (BD Microtainer; no.

365973). Each sample was gently mixed with ∼3 mL of cold HBSS and layered on top of Ficoll
1.084 (GE Life Sciences; no. 17-5446- 02). Samples were spun at 400 × g for 30 min at 18 °C with

no brake. After centrifugation, the upper plasma layer was removed, and the entire mononuclear
layer was transferred to a 50-mL conical tube (Falcon; no. 352098) wetted with a minimal volume
of cold HBSS. Additional cold HBSS was added to the maximum volume of the tube. Tubes then
were spun at 500 × g for 10 min (4 °C), and the supernatants were discarded. The pelleted peripheral blood mononuclear cells (PBMCs) were resuspended in 50 μL of HBSS and were transferred
to a round-bottomed 96- well plate for blocking and staining, as described below.
Both cell preparations (IELs, and PBMCs) were incubated on ice for 20 min with antiCD16/CD32 (clone 2.4G2; BD) to prevent nonspecific staining during subsequent steps. Cells
were washed with 200 μL of ice-cold PBS-BSA, centrifuged at 500 × g for 5 min (4 °C), and the
supernatant was discarded. Cell pellets were resuspended in the appropriate antibody staining
mix. For IELs, this mix included anti-TCR γδ phycoerythrin (clone eBioGL3; eBioscience), antiCD45.2 allophycocyanin (APC)-eFluor780 (clone 104; BD), anti-TCR β V450 (clone H57-597;
BD), and antiB220 V500 (clone RA3-6B2; BD). For PBMCs, this mix was composed of anti47

CD8a FITC (clone 53-6.7; BD), anti-CD4 APC (clone RM4-5; eBioscience), anti-TCR β V450
(clone H57-597; BD), and anti-B220 V500 (clone RA3-6B2; BD).
Live cells were identified by exclusion of the DNA-binding dye 7-aminoactinomycin D
(7-AAD) (Life Technologies) added to the staining mix at a dilution of 1:1,000. After incubation
with these reagents in the dark for 20 min on ice, cells were washed with 150 μL of PBS-BSA,
centrifuged at 500 × g for 5 min (4 °C), and the supernatant was discarded. Cells were kept in the
dark, on ice, until flow cytometry and cell sorting.
Flow cytometry and cell sorting were performed with a FACSAria III instrument (BD
Biosciences) in a laminar flow biocontainment hood (BioProtect IV Safety Cabinet; Baker Co.),
using the manufacturer’s protocol for aseptic sorting. Sheath fluid consisted of autoclaved PBS and
was prepared no more than 1 day before sorting. Cells were sorted into sterile 1.5-mL tubes in a
water-cooled jacket maintained at 4 °C. After sorting, cell purity was validated in a post sort; i.e.,
for every sorted population, 10% of the sorted volume was transferred to a new sterile tube and
analyzed by flow cytometry (see Fig. S1A for the gating strategies).
ATAC-seq.
Transposition and sequencing. Purified, sorted cells (≤50,000 cells per cell type) were prepared
for ATAC-seq transposition following the original published protocol (5), incorporating modifications and optimizations (59). Purified cells from FACS were first centrifuged at 500 × g for 10 min
(4 °C), and the supernatants were discarded. Cell pellets were rinsed with 150 μL icecold PBS and
centrifuged at 500 × g for 10 min (4 °C). The supernatants were discarded, and cell pellets were
resuspended in 25 μL of ice-cold lysis buffer [10 mM Tris·HCl (pH 7.4), 10 mM NaCl, 3 mM
MgCl2, 0.1% (vol/vol) IGEPAL CA-630 (Sigma no. I8896)], followed by centrifugation at 500
× g for 15 min (4 °C). Supernatants were discarded, and the pellets were kept on ice while being
gently resuspended in 25 μL of ATAC-seq transposase reaction mixture [12.5 μL 2× Illumina Tagment DNA (TD) buffer; 10.5 μL nuclease-free water; 2.0 μL Tn5 transposase (Illumina/Nextera
no. FC-121-1030)]. Samples were incubated at 37 °C for 1 h and then were placed immediately on
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ice, and transposed DNA was isolated using a standard PCR purification kit (QIAGEN MinElute
no. 28004).
Isolated DNA samples were transferred to a 96-well PCR plate and amplified for nine
cycles using unique 8-bp indexes per sample (Dataset S1). Cycling conditions were as described in
the original ATAC-seq protocol (5). Following this first amplification, samples were enriched for
smaller fragments using solid-phase reversible immobilization (SPRI) beads. Briefly, after PCR
amplification, samples were mixed with SPRI beads (Beckman Coulter/Agencourt AMPure XP;
no. A63881) at an SPRI to DNA ratio of 0.5 (25 μL SPRI beads). After a 5-min incubation, the
PCR plate was transferred to a magnet stand for separation, and the supernatant was transferred
to a new 96-well plate. Additional SPRI beads were added to an SPRI to DNA ratio of 1.2 (65 μL
of SPRI beads). Samples were mixed at room temperature for an additional 5 min and then were
transferred to a magnet stand for bead separation. The resulting supernatant was discarded, and the
magnet-immobilized beads were rinsed twice with 80% ethanol. The ethanol-washed beads were
airdried following the manufacturer’s instructions. DNA was subsequently eluted in 20 μL of 10
mM Tris·HCl, pH 8.0 (Integrated DNA Technologies; no.11-05-01-13). The size-selected DNA
was subsequently amplified via a second nine-cycle PCR using the same unique 8-bp indexes per
sample and the cycling conditions described in the original ATAC-seq protocol (5). Amplicons
were purified using a standard kit (QIAGEN MinElute no. 28004).
The amplified, uniquely indexed samples were combined and normalized before pooling
and then were sequenced to a target of 25 million reads per sample. Pools were run on an Illumina
NextSeq 75-cycle high-output flow cell (paired-end, 2 × 40+8 bp index) and HiSeq high-output
flowcell (paired-end, 2 × 50+8 bp index). To minimize group effects, samples were chosen so that
each sequencing pool included mice from different experimental groups. Samples that were undersequenced were repooled for subsequent runs.
Computational pipeline. The RIESLING pipeline was developed to process and analyze
ATAC-seq data. RIESLING is a Pythonbased, open-source (license: MIT) pipeline, available at
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https:// github.com/GordonLab/riesling-pipeline. The pipeline was designed for de novo prediction of putative enhancer and superenhancer regions from either single or multiple samples, with
the option of including background or control samples (if available) for comparison. The full
pipeline, detailed in Fig. S2, consists of mapping paired-end sequence data to host genomes (using
Bowtie 2), mitochondrial read filtering (a nuisance in ATACseq, given the open nature of mitochondrial DNA), removal of identical PCR duplicate reads, quality filtering (using adjustable parameters, with a default mapping quality ≥10), and hotspot/ blacklist masking (from the ENCODE
and modENCODE consortia, with varying availability depending on the host organism, or from
internally generated experimental hotspots).
Filtered data were used to perform multistage enhancer prediction, beginning with peak
calling, in which regions with signal higher than background (peaks) were identified using a standard Poisson modeling technique from ChIP-seq [user adjustable, with a default Model-based
Analysis of ChIP-Seq (MACS) (60) and a significance cutoff of P < 1 × 10−9 ]. A window around
known transcription start sites was subsequently masked because of their generally low signal-tonoise ratio in ATAC-seq data (user adjustable, with a default masking of ±2.5 kb), and the raw,
sequenced read depth underlying the identified peaks was computed and summarized using bamliquidator (https://github.com/bradnerlab/ pipeline). Peaks were additionally grouped using one of
three strategies to merge adjacent peaks: (i) unstitched (only the raw peaks without merging); (ii)
fixed stitching, in which peaks within a user-definable window (generally 12.5 kb) are merged to
represent one potential large super-enhancer; or (iii) dynamic stitching, in which the rate of change
of peaks is computed within a window, and the window size is slowly increased to determine an
inflection point. Using these three different approaches to aggregating peaks, predicted enhancers
were graphed using the aggregate signal underlying each enhancer region. Super-enhancers can be
stratified from traditional enhancers by drawing a tangent line to this graph and placing the cutoff
where the slope of this line equals one (this distinction is somewhat arbitrary; see refs. 10 and 11).
Differential accessibility analysis. Differentially accessible regions of chromatin were
identified and classified by applying a negative-binomial model (DESeq2) (61) to counts data out50

put from the RIESLING pipeline. The RIESLING pipeline was used to preprocess (filter, blacklist,
de-replicate reads, call peaks, and so forth) data from each sample, compute the raw read depth,
and then generate a count matrix (read depth per locus in each sample) for input to DESeq2. (Users
also can input these data to alternative analytical packages, including edgeR and baySeq.) Peaks
were selected for inclusion in the counts matrix if they were identified as statistically significant
(based on the MACS Poisson model described above) in any input sample; any overlapping peaks
were merged. Because adjacent peaks are likely to represent the same enhancer regions, RIESLING automatically expands peaks to include nearby peaks within 50-bp, 500-bp, and 1,000-bp
windows (in addition to the unmerged raw data). DESeq2 is then invoked with the default parameters and run at both the genome position level (mm10) and at gene level for comparison (binning
peaks and their associated read depth by proximal gene). For classifying microbiota-responsive
enhancers, we considered groups to be significantly different with P < 0.05.
Normalization. Numerous normalization approaches were compared to determine the
most appropriate choice. For enhancer and super-enhancer characterizations (nondifferential analyses), we used bamliquidator to produce normalized scores of the ATAC-seq signal. This approach
takes each called peak, combined with the underling raw sequencing data, and computes the raw
read counts under each peak, divided by the total sequencing depth and the peak width.
For differential accessibility analyses, we compared results obtained from DESeq2 when
using raw counts data, counts data aggregated by nearby peaks, or counts data following bamliquidator normalization to sequencing parameters (which may violate assumptions of DESeq2’s median normalization model). Comparing these three options revealed that providing raw counts data
to DESeq2 generated the most conservative estimates of differential accessibility (i.e., the fewest
number of differentially accessible regions); therefore we selected that method for our analyses.
DESeq2’s standard normalization approach uses counts data from all peaks and applies a
median-of-ratios method described in ref. 61 to predict unchanging (pseudoreference) regions. We
also considered guiding this median normalization by providing predictions of unchanged (consti51

tutively accessible or condensed) chromatin regions, i.e., de novo regions chosen from overlapping
peaks from our input data and available peaks from public ENCODE datasets. Our de novo peaks
were derived from those shared across groups (GF ∩ CONV-R ∩ CONV-D) and in intersections of
cell types (CD4+ ∩ CD8+, TCR αβ+ ∩ TCR γδ+ IELs ∩ PBMC) and at varying overlap percentages (10, 50, or 90% bp overlap). In these permutations, DESeq2 performed either comparably to
or worse than (i.e., less conservatively, calling more regions as differentially accessible) simply
applying the standard median-of-ratios method to all the input counts data. Using the available
mouse ENCODE data (62) resulted in normalization effects similar to those seen using all raw
counts data, perhaps because the original mouse ENCODE data (i) were generated from heterogeneous tissues not directly comparable to our datasets and (ii) used ChIP-seq. In light of these alternatives, the data in our study reflect the standard DESeq2 median-of-ratios method applied to the
raw input counts data. Pathway analyses. GeNets (https://apps.broadinstitute.org/genets) was used
to identify clusters of functionally associated genes and to group genes by community. The GeNets
random forest classifier was based on the GeNets Metanetwork 1.0 training database, which encompasses InWeb3, ConsensusPathDB, and known drug–target interactions. If multiple enhancers
mapped to a single gene, they were coalesced into one gene for GeNets analysis. Analyses and
community predictions were restricted to the top 250 enhancer-associated genes ranked by ATACseq signal (for super-enhancers) or by P value (when comparing two different colonization states).
GeNets community enrichment significance is based on a Bonferroni-adjusted hypergeometric
test. The GeNets empirical P values for network connectivity are based on gene network density.
The number of edges (interactions between genes) out of the total number of possible edges (the
density) is computed for a given input network as well as for randomly sampled sets of genes; the
density is considered significant if it is greater than that of 95% of the randomly sampled gene sets.
Gene overrepresentation analyses were performed GREAT (18). GREAT 3.0 was run on
predicted enhancer locations (provided from RIESLING) and using the mm10 mouse genome annotation. For identifying proximal genes, the configured parameters of “basal plus extension” were
used (with parameters left at their default values for gene regulatory domain definitions). Back52

ground regions were provided where applicable (to remove potential biases from over- or underrepresented regions from our original peak calling), or the whole mm10 genome was used where
appropriate. DESeq2 differential accessibility data were filtered at P < 0.05 for use by GREAT.
Additional pathway and overrepresentation analyses were performed using IPA (QIAGEN). IPA
was provided log ratios, P values, and the NCBI ID of the nearest gene for each predicted enhancer.
Analyses were run using only the IPA data from “Mouse restricted to Experimentally Observed
data from Epithelial Cells and Immune Cells.”
Analysis of TF Regulatory Circuitry. Network analysis was performed using the Coltron software package (34) available at https://pypi. python.org/pypi/coltron. In each IEL sample,
we identified all dynamically stitched super-enhancer regions associated with TFs. These superenhancer–associated TFs became the cohort of nodes for the network analysis. Edges were defined
as predicted TF-binding sites within ATAC-accessible regions found inside super-enhancers. Thus,
for any given TFi, connectivity could be described as how it is regulated itself (IN degree) and how
it regulates the super-enhancers of other TF nodes in the network. IN degree and OUT degree are
normalized from 0 to 1 where 0 indicates that no TF-binding sites are predicted, and 1 indicates
that all TFs have a predicted binding site. Multiple TFbinding sites in a super-enhancer from the
same factor are considered a single edge in the degree calculations. Enriched TF-binding sites
were predicted using the FIMO algorithm (63) trained on TF position weight matrices defined in
the TRANSFAC database (64). A false-discovery rate cutoff of 0.01 was used to identify enriched
TF-binding sites.
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Supplemental figure legends
Fig. S1.
FACS sorting strategies and reproducibility of ATAC-seq datasets. (A) Gating strategies for both
IEL populations. Live TCR αβ+ and TCR γδ+ IELs from the small intestine were sorted simultaneously. (B) Venn diagrams showing the total number of putative enhancers within and between
the four cell types studied. (C) ATAC-seq read counts per predicted enhancers identified from each
cell preparation were normalized using a negative binomial model (via DESeq2). Pairwise comparisons were then performed within a given treatment group. Pearson correlation values (mean ±
SEM) are plotted for each group.
Fig. S2.
Overview of the RIESLING pipeline. The RIESLING pipeline was developed to characterize enhancer regions in ATAC-seq data rapidly and to generate output for processing with additional
tools (e.g., DESeq2, edgeR, baySeq, and others) to identify differentially accessible regions of
chromatin. (A) Input to this pipeline is de-multiplexed paired-end sequencing reads. (B–D) Reads
are mapped to a host genome (via bowtie2) (B) and then are filtered for mitochondrial reads and
ENCODE blacklists (65) (C) and de-duplicated (D). (E) Peaks are called using a user-selectable
peak caller (60). (F) The preprocessed data undergo signal aggregation using bamliquidator. (G
and H) RIESLING internally filters transcriptional start sites (TSS) and promoters (G) and then
predicts enhancer regions using one of three peak stitching approaches: unstitched (raw peaks);
dynamic stitching, based on the rate of change of enhancer prediction vs. a growing window; or
fixed stitching in which peaks within a user-selectable parameter (generally 12.5 kb) are merged
(H). (I) These regions are then ranked by signal (normalized read depth), and super-enhancer (SE)
regions are separated from traditional enhancers. (J and K) RIESLING calls enhancer-proximal
genes based on user-specified parameters (J) and prepares a counts matrix for differential accessibility analysis (K). (L–N) For differential accessibility analysis, the output of RIESLING is used
as input to DESeq2 to generate quality control graphs (L) and differential accessibility analyses
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(M), including optional pathway and overrepresentation analyses (N). For additional details of the
pipeline and source code availability, see SI Materials and Methods, Computational pipeline.
Fig. S3.
The enhancer landscape of TCR αβ+ and TCR γδ+ IELs and peripheral CD4+ and CD8+ T cells,
independent of colonization status. (A) Hierarchical clustering of enhancers identified in ATACseq datasets shows clear separation of IEL populations from circulating T cells. Clustering was
performed on Jaccard distance metric scores between peaks from a given cell type (shown in blue
shading where a value of 1.0 reflects complete overlap). (Left) All enhancers. (Right) Super-enhancers. (B) Distribution of enhancer signals in TCR αβ+ IELs and TCR γδ+ IELs, demonstrating
a hockeystick asymmetric distribution. Super-enhancers were stratified from traditional enhancers by the point on the exponential curve where the slope approaches 1. The vertical dashed line
represents the cutoff between traditional and super-enhancers. A subset of super-enhancers and
their adjacent genes is highlighted. (C) Distribution of enhancer signals in CD4+ and CD8+ T
cells. Super-enhancers with the top-ranked signal intensity are annotated with their most proximal
gene. (D) The Bach2 super-enhancer overlaid on normalized sequencing data (reads per kilobase
per million reads, within a 50-bp bin) from the TCR αβ+ and TCR γδ+ IEL populations. Genomic
information for Bach2 and its neighbors are from mm10 RefSeq.
Fig. S4.
Predicted GeNets communities from both IEL lineages. (A) A network and community clustering
analysis performed using GeNets, applied to the top 250 super-enhancer–associated genes shared
by TCR αβ+ and TCR γδ+ IELs, independent of colonization status. Nodes represent genes, and
edges (lines) represent gene–gene interactions. Note that there is significant connectivity between
networks (P < 0.005; permutation test of nodes). See Datasets S6 and S7 for an alternative GREATbased analysis of pathways enriched in the various purified cell populations independent of colonization status. (B) Each individual community is expanded here for both TCR αβ+ and TCR γδ+
IELs, with each node representing a super-enhancer–associated gene and each edge representing a
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gene–gene interaction (based on a network including ConsensusPathDB and InWeb3; see SI Materials and Methods, Pathway analyses). A description of each gene and analyses of overrepresented
pathways in each community are available in Dataset S3.
Fig. S5.
Enhancer populations distinguish IEL lineages. (A) The dynamic stitching model from RIESLING
applied to the IEL population (independent of colonization status), demonstrating a window of
2.5 kb for grouping together nearby predicted enhancers. (B) Enhancers distinguishing lineages
independent of host colonization status. (C) Enhancers distinguishing TCR αβ+ IELs as a function
of colonization status. (D) Enhancers distinguishing TCR γδ+ IELs as a function of colonization
status. (E) Histograms representing the distribution of fold change (log2) in dynamically stitched
enhancers identified as statistically significant to our stringent threshold (P < 5 × 10−5) in GF vs.
CONV-R TCR αβ+ and TCR γδ+ IELs. (F) A histogram of fold change (log2) of dynamically
stitched enhancers identified as statistically significant (P < 5 × 10−5) in CD4+ vs. CD8+ T cells.
Fig. S6.
Comparison of gut microbial community structure in CONV-R and CONV-D mice. Bacterial 16S
rRNA analysis was performed on fecal samples obtained when 8-wk-old mice were killed. CONVD animals were colonized at 3 wks of age. The fecal microbiota of CONV-D and CONV-R animals
had similar alpha-diversity with no significant differences detected in Faith’s phylogenetic diversity (P = 0.395, ANOVA), Shannon’s diversity (P = 0.301, ANOVA), or the number of observed
97% ID OTUs that survived our initial filtering and rarefaction (P = 0.646, ANOVA). (A) Heatmap
of the relative abundances of the most strongly associated OTUs for the CONV-D and the CONVR groups of mice, as judged by the differences in their indicator values. Relative abundance is
calculated as the base 10 log of the number of reads (plus one) per 5,000 reads. (B) Phylogenetic
tree showing evolutionary relationships between the V4-16S rRNA sequences of the significant
indicator OTUs. OTUs in red were positively associated with CONV-R mice, and OTUs in blue
were positively associated with CONV-D mice. An approximately-maximum-likelihood phyloge56

netic tree was constructed using the FastTree method implemented in QIIME. PERMANOVA revealed significant differences in the phylogenetic composition and structure of the fecal microbiota
of CONV-D compared with CONV-R mice based on a number of metrics [unweighted UniFrac
distances (P = 0.001, R2 = 0.422); weighted UniFrac distances (P = 0.001, R2 = 0.571); and binary
Jaccard dissimilarities (P = 0.001, R2 = 0.298)].
Fig. S7.
Track graphs comparing normalized median ATAC-seq signals obtained from analysis of TCR αβ+
IELs purified from CONV-R and GF mice. Tracks represent the normalized signal at enhancers
near Stat1 and Stat3 and demonstrate the increased signal at Stat3 in GF TCR αβ+ IELs compared
with CONV-R TCR αβ+ IELs (P < 0.05, Benjamini–Hochberg-adjusted Wald test). Binding motifs
for a subset of TFs implicated in the IEL TF regulatory circuitry are annotated; outlined in red are
the JUN/FOS and MAFK bZIP TFs that have binding sites in Stat3 but not in Stat1. Both TCR αβ+
and TCR γδ+ IELs show enrichment in GF mice compared with CONV-R mice at a second (intronic) enhancer (P < 0.05, Benjamini–Hochberg-adjusted Wald test). No statistically significant
differences were noted between ATAC-seq signals from enhancers in Stat1 when comparing the
IEL populations from GF and CONV-R animals. For a more global view of differential accessibility, see Fig. S5.
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Future Directions
This thesis was enabled by the bleeding edge of technology. At the start of these experiments, and
during an unpublished proof-of-concept experiment, ATAC-seq was nascent. It was unclear if the
technology could be adapted from its original paper (which looked primarily at human CD4+ T
cells) to subpopulations of mouse immune cells, and used to call putative enhancer loci. My studies suggest one potential mechanism by which the microbiota induces durable effects in its host.
Several follow-up studies are warranted.
First, although ATAC-seq is in part empowered by its histone-agnostic approach to chromatin characterization, detailed data on individual histone modifications would be very valuable
in determining which specific modifications may underlie changes in chromatin accessibility. At
the start of this project, this wasn’t feasible with such small cell populations, though some recent
technologies (iChIP (Lara-Astiaso et al. 2014)) may be of value when applied to these and/or other
populations. iChIP is an index-first modification to ChIP-seq that could potentially assay numerous histone marks in small populations of cells. Unfortunately, in a small collaboration with my
colleague David Russler-Germain, we were unable to reproduce this technique. Since then, other
techniques have been published aiming to enable ChIP-seq and related techniques using small
numbers of cells, including Mint-ChIP (a multiplexed ChIP-seq-based approach employing linear
amplification (van Galen et al. 2015)), scM&T-seq (parallel, single-cell parallel sequencing of the
transcriptome and methylome (Angermueller et al. 2016)), and single-cell versions of DNAse-seq
and ATAC-seq (Jin et al. 2015; Buenrostro et al. 2015; Cusanovich et al. 2015). An alternative approach would be to look even more globally at chromatin architecture. One novel method (ChromATin, Linhoff et al. 2015) takes this global view, and provides 3D chromatin architecture in large
and structurally complex tissues. This technique, which uses high-resolution imaging combined
with fixation and immunostaining, could potentially be applied across the layers of the small intestine, where marked differences in chromatin landscape may exist between the same cell type
localized at the junction between the epithelium and underlying lamina propria, or deeper within
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the submucosa (e.g., tissue-resident macrophages or neurons traversing the intestinal layers may
show markedly different chromatin compaction or localization of specific histones).
Secondly, this work would be enhanced by exploring potential pharmacologic or dietary
components that influence enzymes and pathways responsible for microbiota-mediated host chromatin remodeling and histone modification. Recent work has suggested that high dietary fat intake
can induce significant changes in hepatic chromatin landscape (assayed by FAIRE-seq; a common
formaldehyde cross-linking technique that is similar to DNase-seq in 4–6 week-old C57BL/6J and
DBA/2J mice fed a standard 10% fat/kcal vs 30% fat/kcal diet for eight weeks) and related transcriptional pathways (via hepatic RNA-seq) (Leung et al. 2014).
It would be fascinating to apply this approach to the study of populations suffering from
malnutrition. The literature on epigenetic impacts of malnutrition is complex, and largely focused
on either single nutrient deficiencies, or on broad studies of methylation. For example, one recent
study identified significant perturbations (generally hypomethylation) in the mouse sperm methylome following parental undernutrition (Radford et al. 2014). In one of the few studies of undernourished humans, whole peripheral blood showed differential methylation at numerous loci —
including some linked to the insulin receptor — in individuals with prenatal exposure to the Dutch
Hunger Winter (at the end of World War II) (Tobi et al. 2014). It could be extremely informative
to apply the approaches outlined in this thesis to the gnotobiotic mouse model described in the Appendix, where animals were colonized with culture collections generated from the fecal microbiota
of Bangladeshi children with severe acute malnutrition or with healthy growth phenotypes, fed a
diet representative of those consumed by the donors. In these studies, weight loss phenotypes with
associated alterations host energy metabolism were dependent on the presence of an enterotoxigenic strain of Bacteroides fragilis (ETBF). The weight loss phenotype could be prevented by the
presence of a non-toxigenic strain, was diet-dependent, and could be transmitted across generations. We used ATAC-seq to characterize the chromatin landscape in splenic CD4+ and CD8+ T
cells harvested from these mice. Although we noted few statistically significant changes between
mice harboring the stunted donors ETBF(+),NTBF(-) culture collection versus the healthy donors
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NTBF(+),ETBF(-) culture collection, our work could be limited by our choice of splenic T cells,
which was restricted by sample availability. A logical follow-up series of experiments would be
to generate ATAC-seq profiles from IELs or other cell populations exposed more directly to the
microbiota and its products (e.g., hepatic Kupffer cells).
Other intergenerational models of malnutrition are also ripe for investigation, including
one of a collaborator who has identified that maternal undernutrition in mice can result in metabolic disease and insulin resistance in offspring (reviewed in Patti 2013). It is possible that this
intergenerational phenotype reflects microbial contributions to the host, either during in utero development or from postnatal colonization.
Finally, it will be of value for future researchers to expand the computational platform and
associated visualization tools developed in this thesis. Since this study began, the broad field of
epigenetic profiling has expanded to include more expression data, frequently by parallel RNAseq of samples. Integration of RNA-seq data into the RIESLING pipeline for enhancer prediction
could be helpful, however not without potential complications. RNA recovered from cells after
their purification may not accurately reflect the features of gene expression in vivo. Notably, the
state of chromatin can be more indicative of cell identity and cell state than gene expression data
(Stergachis et al. 2013), and chromatin can encode functional capabilities that are not reflected in
RNA (Samstein et al. 2012; John et al. 2011). Additionally, as the epigenetic field has expanded,
many studies now focus on even smaller cell populations, including the use of single-cell ATACseq. Expanding this software toolkit to analyze single-cell experiments could be of great value
to future research, and would help standardize what can be otherwise piecemeal analytical approaches.
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mice fed diets similar to those consumed by the human donors has
provided preclinical evidence for a causal role of the gut community
in disease pathogenesis (6–8). Young mouse recipients of undernourished
donors’ microbiota exhibit growth faltering, manifested in part by a
reduced rate of lean body mass gain compared to recipients of healthy
donors’ microbiota. These differences are not associated with differences in food consumption (6). Adult mouse recipients of undernourished
donor’s microbiota exhibit a weight loss (wasting) phenotype (7, 8).
A large enteropathogen burden is associated with childhood undernutrition (9, 10). However, the effects of microbiota configuration on
enteropathogen invasion and burden, or how community context influences the expressed properties of organisms classified as enteropathogens in children at risk for or already showing undernutrition, remain
poorly understood. Identifying gut community configurations that are
resistant to invasion or accommodate organisms currently classified as
enteropathogens without supporting their ability to produce deleterious
host effects has potential diagnostic and therapeutic implications.
Bacteroides fragilis provides a model for examining how community
context, including intraspecific interactions involving different strains
of a given species and interspecific interactions involving different species, affects the properties of an enteropathogen and its effects on the
host. Enterotoxigenic B. fragilis (ETBF) strains contain one of three
alleles of B. fragilis toxin (bft-1, bft-2, and bft-3) in their 6-kb pathogenicity island (BfPAI). The bft locus encodes a zinc-dependent metalloprotease, fragilysin, that perturbs gut barrier function through cleavage
of E-cadherin at epithelial cell adherence junctions (11). ETBF strains
cause diarrhea in children residing in Bangladesh (12, 13). Nontoxigenic
B. fragilis strains (NTBF) lack bft. Thus, B. fragilis can be viewed as a
potentially pathogenic symbiont (pathobiont) on the basis of the presence or absence of this gene, or more broadly, on the basis of its community context.
Here, we describe a gnotobiotic mouse model for analyzing how
intraspecific and interspecific interactions determine the effects of
ETBF. We started with fecal samples collected from Bangladeshi

INTRODUCTION

Undernutrition is the leading cause of childhood mortality worldwide;
it is not due to food insecurity alone but rather reflects a complex and
incompletely understood set of interactions involving a variety of factors
that operate within and across generations (1–4). Among these factors is
the gut microbiota. A recent culture-independent study of fecal microbiota samples collected monthly from members of a Bangladeshi birth
cohort with healthy growth phenotypes identified age-associated
changes in the representation of bacterial species during the first 2 years
of postnatal life (5). These age-discriminatory species together define a
developmental program for the microbiota that is shared across biologically unrelated Bangladeshi infants and children (5). Children with
moderate or severe undernutrition exhibit disruptions in this program,
resulting in microbial communities that appear younger than those of
chronologically age-matched healthy individuals (5, 6). Clinical studies
have provided evidence that microbiota immaturity in children with severe acute undernutrition is not repaired when they are fed therapeutic
food supplements (5). Transplantation of fecal microbiota from children with healthy growth phenotypes, or immature microbiota from
chronologically age-matched undernourished children, into germfree
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To model how interactions among enteropathogens and gut microbial community members contribute to
undernutrition, we colonized gnotobiotic mice fed representative Bangladeshi diets with sequenced bacterial
strains cultured from the fecal microbiota of two 24-month-old Bangladeshi children: one healthy and the other
underweight. The undernourished donor’s bacterial collection contained an enterotoxigenic Bacteroides fragilis
strain (ETBF), whereas the healthy donor’s bacterial collection contained two nontoxigenic strains of B. fragilis
(NTBF). Analyses of mice harboring either the unmanipulated culture collections or systematically manipulated
versions revealed that ETBF was causally related to weight loss in the context of its native community but not
when introduced into the healthy donor’s community. This phenotype was transmissible from the dams to their
offspring and was associated with derangements in host energy metabolism manifested by impaired tricarboxylic acid cycle activity and decreased acyl–coenzyme A utilization. NTBF reduced ETBF’s expression of
its enterotoxin and mitigated the effects of ETBF on the transcriptomes of other healthy donor community
members. These results illustrate how intraspecific (ETBF-NTBF) and interspecific interactions influence the
effects of harboring B. fragilis.
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either time point, only this stunted/underweight child was positive at
both 18 and 24 months of age. Fecal samples obtained from members
of this singleton birth cohort were screened for parasites using microscopic methods (5); neither of the two donors tested positive (see
Materials and Methods for details).
To define the effects of diet and these two childrens’ gut microbiota on
host biology, we generated three representative versions (embodiments)
of the diets consumed by the population represented by the donors. To do
so, we determined the relative daily caloric contributions of various
selected ingredient types, based on a study by Arsenault and coworkers
(16). Selection of specific food items as representative of each ingredient
type was based on consumption incidence surveys tabulated by Islam
et al. (17), and the results were incorporated into a database consisting
of 54 food ingredients. We filtered this database to remove items consumed by <20% of households and categorized each of the remaining
39 items (see Materials and Methods for additional details). From the
resulting diet ingredient matrix, we randomly sampled (without replacement) one item each from cereals, pulse vegetables, roots/tubers,
leafy vegetables, fruits, and fish, plus three nonleafy vegetables, to populate three separate diet lists. Using the U.S. Department of Agriculture National Nutrient Database for Standard References (18), we
determined the caloric information for each ingredient and subsequently calculated proportions required to match the predetermined
contributions of each ingredient type. Food items were cooked in a
manner intended to simulate Bangladeshi practices, and the resulting
three embodiments of a Bangladeshi diet were sterilized by irradiation.
This approach allowed us to generate several representative Bangladeshi
diets that were not dominated by the idiosyncrasies of a single individual’s diet or by our own biases. The composition and results of
nutritional analysis of the three diet embodiments are described in
table S2 (A and B). The nutritional requirements of mice and children
are compared in table S2C.
The results of a 12-year survey of demographic variations in the
nutritional status of 16,278 Bangladeshi children found no significant sex differences in WHZ, WAZ, or HAZ (19). Therefore, in these
and subsequent experiments, we eliminated gender as an experimental
variable and only studied male mice. We gavaged separate groups of
8- to 9-week-old germfree C57BL/6 mice with the intact uncultured
fecal microbiota samples obtained from the healthy or stunted/
underweight Bangladeshi donors (two independent experiments; n =
4 singly caged mice per donor microbiota per experiment; see fig.
S1A for study design). Fecal microbiota transplantation occurred 2 days
after mice had been switched from an irradiated, nutritionally complete,
low-fat/high-plant polysaccharide (LF/HPP) mouse chow that they had
received since weaning to the first of the three embodiments of the
Bangladeshi diet. Animals were subsequently fed, ad libitum, embodiment 1 for 1 week, followed by embodiment 2 for 1 week, and finally
embodiment 3 for 1 week, with frequent sampling of their fecal microbiota during the course of each diet. Sequencing PCR amplicons generated from variable region 4 (V4) of bacterial 16S ribosomal RNA
(rRNA) genes present in the donor’s fecal sample and in fecal samples
collected over time from recipient gnotobiotic mice (table S3) provided
an in vivo assay of colonization efficiency for each human donor sample. 16S rRNA sequencing reads were grouped into operational taxonomic units (OTUs) on the basis of a threshold of ≥97% nucleotide
sequence identity (97% ID). The results revealed that at the conclusion
of the experiment, 65.8 ± 2.5% (mean ± SEM) of OTUs in the stunted/
underweight donor’s fecal microbiota sample and 68.4 ± 8.8% (mean ±
SEM) of the OTUs in the healthy donor’s microbiota were detectable in

RESULTS

Uncultured fecal gut microbiota from an underweight donor
confers weight loss on gnotobiotic mice
We used anthropometric data collected from members of a birth cohort
study (14) of 100 children living in Mirpur thana in Dhaka, Bangladesh,
to define whether they were healthy or undernourished (table S1).
Those with height-for-age z scores (HAZ) greater than or equal to −2
were classified as “healthy,” whereas those with scores less than or equal
to −3 were deemed severely stunted. At 18 months, 30 and 25 children
satisfied these criteria for healthy and severely stunted, respectively,
whereas at 24 months, 27 and 20 children received these designations;
the remaining children were classified as moderately stunted (HAZ between −2 and −3). A PCR-based screen for ETBF targeting all three
fragilysin gene subtypes (14) was performed using DNA isolated from
fecal samples that had been collected from these children at 18 and
24 months of age. The results revealed that ETBF was variably present
between individuals and within a given individual over time, with a total
of 25% of 18-month-old and 14% of 24-month-old children having a
positive test (table S1). In this small cohort, ETBF carriage was not significantly correlated with indices of linear or ponderal growth [HAZ,
weight-for-age z score (WAZ), and weight-for-height z score (WHZ)
measured at 12 and 24 months of age (P = 0.8 and P = 0.4, P = 0.7
and P = 0.2, and P = 0.5 and P = 0.2, respectively; two-tailed Student’s
t test)]. We combined anthropometric and PCR data to select fecal
samples collected at 24 months from two children: (i) a healthy individual (child ID 7114 in table S1) with a HAZ score of −0.71, a WAZ score
of −1.49, and a WHZ score of −1.62 who was ETBF-negative at the two
time points tested, and (ii) a severely stunted and moderately
underweight individual (child ID 7004) with a HAZ score of −3.02, a
WAZ score of −2.51, and a WHZ score of −1.34 who was ETBF-positive
at both time points. Of the 35 individuals with a positive ETBF test at
Wagner et al., Sci. Transl. Med. 8, 366ra164 (2016)
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children who were participants in a previously completed birth cohort
study (14). Using anthropometric scores to define healthy growth versus stunting and wasting (15), and a polymerase chain reaction
(PCR)–based assay that targeted bft, we selected two chronologically
age-matched individuals: one markedly stunted, underweight, and
ETBF-positive, and the other with a healthy growth phenotype who
was ETBF-negative but NTBF-positive. We transplanted intact uncultured fecal microbiota samples, collected from these two children
at 24 months of age, into adult germfree mice. These gnotobiotic mice
were fed cooked diets containing ingredients embodying those consumed by the population from which the microbiota donors were
selected. Finding that the severely stunted and underweight but not
the healthy donor’s microbiota transmitted a weight loss phenotype
to recipient animals and subsequently to their offspring, we performed
follow-up transplant studies using clonally arrayed collections of sequenced anaerobic bacterial strains cultured from the donors’ fecal
samples. These culture collections allowed us to dissect microbemicrobe and host-microbe interactions by testing the effects of several types of manipulations: (i) removing the ETBF strain from the
stunted donor’s cultured community, (ii) introducing the ETBF strain
into the healthy donor’s culture collection together with or in lieu of
its own NTBF strains, and (iii) introducing the NTBF strain into the
stunted donor’s culture collection together with or in lieu of its own
ETBF strain. Microbiota community structure and gene expression,
microbial and host metabolism, and host weight and immune phenotypes were characterized as a function of these alterations.
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recipient mice (that is, each OTU had a relative abundance of ≥0.1% in
≥1% of fecal samples obtained from the animals).
Although gnotobiotic animals colonized with the healthy donor’s
intact uncultured fecal microbiota maintained weight, recipients of
the severely stunted/underweight donor’s intact uncultured fecal microbiota exhibited progressive and significant weight loss (P < 0.005, paired
two-tailed Student’s t test, comparison of final versus initial weights
between the two treatment groups; Fig. 1A). In contrast to mice colonized with the healthy donor’s microbiota, those that received the
stunted donor’s microbiota exhibited statistically significant weight
loss at 10 days postgavage (dpg), during consumption of diet embodiment 2. Weight loss in this group worsened progressively, reaching
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donor’s culture collection in the context of all three embodiments of the Bangladeshi diet. *P < 0.05 (paired two-tailed Student’s t test and linear mixed effects model).
(E) Intergenerational transmission of discordant weight phenotypes. See fig. S1C for experimental design. Mean weights (±SEM) of offspring of female gnotobiotic mice
colonized with the indicated donors’ microbiota (n = 3 to 4 mice per treatment group) are plotted as a function of age. Animals were switched from a nutrient sufficient
LF/HPP mouse chow to embodiments of the Bangladeshi diets beginning on postnatal day 56. *P < 0.05 (tested by both paired two-tailed Student’s t test comparing weights
at killing and linear mixed effects model assessing interaction of weight, dpg, and microbiota through the experiment). The efficiency of intergenerational transmission of 97%
ID OTUs was 96 ± 1.8% and 88 ± 2.3% (mean ± SEM) for the healthy and stunted/underweight donor’s microbiota, respectively (defined at the time of killing).
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Fig. 1. Intact uncultured human fecal microbiota and derived culture collections from
healthy and undernourished Bangladeshi
children transmit discordant weight phenotypes to gnotobiotic mice. (A) Germfree male
C57BL/6 mice (8 to 9 weeks old) (n = 8 per treatment group) gavaged with intact uncultured
fecal microbiota from Bangladeshi donors were
fed a sequence of three embodiments of a representative Bangladeshi diet consumed by members of the donor population. See fig. S1A for
experimental design. Mean weights (±SEM) as a
function of dpg are shown as percentages of
weights immediately before fecal microbiota
transplantation. (B) Efficiency of capture of bacterial OTUs present in the donor’s intact uncultured
fecal samples in gnotobiotic mice. Mean relative
abundances (±SEM) of 97% ID OTUs representing
≥1% of the total fecal microbial communities in
recipient animals. Results are based on V4-16S
rRNA data sets and summarized at the species
level (or genus when species could not be determined). OTUs present at lower abundances are
not shown and account for the proportion not
represented in each stacked barplot. (C) Transplantation of culture collections (dashed lines)
generated from the fecal microbiota of the healthy
or stunted/underweight donors recapitulated the
discordant weight phenotype seen with the corresponding intact uncultured microbiota (solid
lines) (n = 6 mice per treatment group, mean
weights ± SEM plotted). *P < 0.05 (paired twotailed Student’s t test and linear mixed-effects
model, as above). (D) The weight-loss phenotype
observed in recipients of the stunted/underweight
donor’s culture collection is not significantly different between the three Bangladeshi diet embodiments tested (P > 0.05; two-tailed Student’s t test).
Mean weights (±SEM) are plotted as a function of
dpg (n = 6 mice per culture collection per diet embodiment). Significant weight differences were
seen between mice colonized with the healthy
donor’s compared to the stunted/underweight

31 ± 6% (mean ± SEM) of original starting weight by 21 dpg (P <
0.001, two-tailed Student’s t test, comparison of final weights; Fig.
1A); in a linear mixed-effects model, both dpg and the interaction
between microbiota and dpg were significant factors affecting weight
throughout the experiment (P < 1 × 10−7 for each). Food consumption was not different between the two treatment groups as their
weight phenotypes diverged. The relative abundance of B. fragilis,
defined by V4-16S rRNA analysis of fecal samples obtained at the
time of killing, was significantly greater in mice colonized with the
stunted/underweight donor’s microbiota than in mice colonized with
the healthy donor’s microbiota (P = 1.9 × 10−6, two-tailed Student’s
t test; Fig. 1B).
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collections into separate groups of 8-week-old adult male germfree
C57BL/6 mice who were monotonously fed Bangladeshi diet embodiment 1, 2, or 3 for 3 weeks (n = 6 singly caged recipient mice
per culture collection per diet embodiment; fig. S1B). The discordant
weight phenotype observed previously was preserved irrespective of
the Bangladeshi diet embodiment consumed (P < 0.01, two-tailed
Student’s t test, comparison of final weights of mice regardless of diet
embodiment consumed; n = 18 mice per culture collection; Fig. 1D).
Moreover, no significant differences in weights were noted between
groups of mice colonized with the same culture collection but fed
different diet embodiments (P > 0.05 for embodiments 1 versus 2, 1 versus 3, and 2 versus 3; two-tailed Student’s t test, comparison of final
weights; Fig. 1D).
Transmission of strains was assessed by short-read shotgun sequencing of DNA isolated from fecal samples collected at the end of the experiment. This method, known as community profiling by sequencing
(COPRO-Seq) (21), maps reads onto the draft genome assemblies of
community members. At the depth of sequencing used [354,352 ±
23,216 (mean ± SEM), 50-nucleotide (nt) unidirectional reads/fecal
DNA sample], we could reliably detect strains whose relative abundance
is ≥0.1%. COPRO-Seq demonstrated that transplantation of the culture
collections was efficient and reproducible, with 98.1 ± 0.6% and 94.5 ±
1.6% (mean ± SEM) of strains in the collections derived from the
healthy and stunted donors, respectively, appearing in recipient
animals. The relative abundance of ETBF in the fecal microbiota of mice
containing the stunted/underweight donor’s culture collection was significantly greater than the cumulative relative abundance of the two
NTBF strains in recipients of the healthy culture collection irrespective
of the diet embodiment consumed (75.5 ± 4.1% versus 17.0 ± 4.4%; P =
2.8 × 10−9, two-tailed Student’s t test; Fig. 2A). The relative abundances
of the ETBF strain in recipients of the stunted/underweight donor’s
culture collection, the two NTBF strains in the healthy donor’s collection, and all other Bacteroides species did not differ significantly between diet embodiments [P > 0.2 for all Bacteroides, one-way analysis
of variance (ANOVA); Fig. 2B].
Intergenerational transmission of weight phenotypes.
To assess whether this weight loss phenotype was transmissible across
generations of mice, two C57BL/6 male mice from the transplant experiment, one containing the stunted/underweight donor’s culture
collection and the other containing the healthy donor’s collection,
were switched to and subsequently maintained on an irradiated nutritionally enhanced mouse breeder chow from 21 to 48 dpg, at which
time they were each cohoused with two germfree 6-week-old female
mice that had received breeder chow since weaning. Seven days after
cohousing, each male mouse was withdrawn from each mating trio,
and the female mice were subsequently maintained on breeder chow
throughout their pregnancy and as their pups completed the suckling
period (fig. S1C). Male pups (n = 3 to 4 per litter) were then weaned
onto an irradiated, nutritionally sufficient, LF/HPP chow, until they
were 9 weeks old, at which time they were switched to the Bangladeshi
diets (10 days per diet; same order of sequential presentation of the
embodiments as before). Mice born to mothers colonized with either
of these arrayed culture collections experienced identical weight gain
profiles while consuming the LF/HPP diet (P = 0.9, two-tailed Student’s t test; table S6). However, once they were transitioned to the
sequence of three Bangladeshi diet embodiments (consumed from
postnatal days 56 to 86), mice born to mothers harboring a stunted/
underweight donor’s microbial community exhibited significantly
greater weight loss (P = 0.03, two-tailed Student’s t test comparing
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Bacterial culture collections from donor fecal microbiota
transmit contrasting weight phenotypes
We next cultured bacterial strains from the healthy and stunted/
underweight donors’ fecal samples (20, 21). Each collection of cultured
strains was clonally arrayed in multiwell plates so each well contained
a monoculture of a given bacterial isolate (20). Each culture collection
consisted of organisms that had coexisted in the donor’s gut and thus
were the products of the donor’s history of environmental exposures
to various microbial reservoirs (including those of family members
and various enteropathogens endemic to the Mirpur thana), as well
as the selective pressures and evolutionary events placed on and operating within their microbiota (for example, immune, antibiotic, dietary,
and horizontal gene transfer). Individual isolates in the clonally arrayed
culture collection were grouped into “strains” if they shared an overall
level of nucleotide sequence identity of >96% across their assembled
draft genomes (21). On the basis of this criterion and the results of
sequencing amplicons generated from the isolates’ 16S rRNA genes,
we determined that the healthy and stunted donors’ culture collections
contained 53 and 37 strains, respectively. Only one strain was shared
between the two culture collections: Bifidobacterium breve hVEW9
[see table S4 for a list of all isolates in the culture collection derived from
the stunted/underweight child and (21) for details of the healthy donor’s
culture collection]. The two B. fragilis strains present in the healthy
donor’s culture collection (hVEW46 and hVEW47) lacked a BfPAI
and were therefore classified as NTBF. The stunted donor’s collection
contained a single B. fragilis strain (mVEW4) with a bft-3 allele. ETBF
strains of this type are globally distributed but most common in Southeast Asia (22) (see table S5 for a comparison of the functions encoded by
genes in the genomes of these ETBF and NTBF strains and the reference
B. fragilis type strain ATCC 25285).
To ascertain whether the contrasting weight phenotypes conferred
by the two intact uncultured fecal microbiota samples could be
transmitted by the strains captured in their derivative culture collections, we colonized 8-week-old adult male germfree C57BL/6 mice with
all members of either of these two culture collections (n = 6 singly caged
mice per collection; all mice receiving a given culture collection were
maintained in a single gnotobiotic isolator). As a reference control for
this experiment, and to compare results between this and the previous
experiment, we colonized mice with the corresponding intact uncultured fecal microbiota samples, housing these mice in separate
isolators from those used for the culture collection transplants. All
mice were fed three embodiments of the Bangladeshi diet (1 week
per diet) in the same order described for the previous experiment. As
with the intact uncultured microbiota, the corresponding culture
collections transmitted discordant weight phenotypes to recipient
animals (P < 0.002, two-tailed Student’s t test, comparison of final
weights; Fig. 1C). Moreover, the weight phenotypes (change in body
weight over time as a percentage of initial weight before gavage) observed with each intact uncultured fecal microbiota and the corresponding derivative culture collection were not significantly
different (P > 0.05 for both microbiota donors, two-tailed Student’s
t test; Fig. 1C). The difference in weight phenotypes first became statistically significant between the two groups of mice midway through
consumption of diet embodiment 2, continued to increase with diet
embodiment 3 (Fig. 1C), and again were not attributable to differences
in food consumption.
Effect of diet.
To test whether the weight loss phenotype was sensitive or robust to diet
embodiment type, we gavaged the two clonally arrayed bacterial culture
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weights at killing). The total relative abundance of the two NTBF
strains in fecal samples obtained from recipients of the healthy donor’s
culture collection was 4.2 ± 0.7% at the conclusion of the LF/HPP diet
period and 4.6 ± 0.9% at the conclusion of the Bangladeshi diet
embodiment sequence, whereas the relative abundance of ETBF at
these two time points was 34.3 ± 4.2% and 50.0 ± 0.7%, respectively,
in mice colonized with the stunted/underweight donor’s culture
collection.
An independent intergenerational transfer experiment was performed, in this case using the donors’ intact uncultured fecal microbiota. The efficiency of ETBF and NTBF transmission from
mothers to pups was 100%. As with the culture collections, there
was diet-dependent transmission of the discordant weight loss phenotype (Fig. 1E; compare with Fig. 1A).
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Microbial community context determines the effects of ETBF
on community members and host
To establish whether ETBF is necessary and sufficient to cause
marked weight loss in multiple community contexts, we performed
a series of manipulations that involved removing the ETBF strain
from the stunted/underweight donor’s culture collection and adding it to the healthy donor’s culture collection, with or without subtraction of its two NTBF strains (Fig. 2C). These manipulations
allowed us to characterize (i) the role of community context in determining ETBF pathogenicity, (ii) the community/host responses to
ETBF, (iii) the ability of NTBF to modulate ETBF effects, and (iv)
the effects of ETBF on NTBF. Recipient C57BL/6 male mice in each
of the different treatment groups were 8 to 9 weeks old at the time of
colonization; all were placed on diet embodiment 2 for 2 days before
77

5 of 14

Downloaded from http://stm.sciencemag.org/ on March 16, 2017

Fig. 2. ETBF is necessary but not sufficient to
produce weight loss in recipient gnotobiotic
mice. (A) Gut microbial community composition, defined by COPRO-Seq, in mice colonized
with either of the two unmanipulated culture
collections or the derived manipulated versions. Mean values for relative abundances ±
SEM are plotted using aggregate data generated from fecal samples collected from mice
colonized with a given community. Taxa present at abundances lower than 1% are not represented in the stacked barplots. (B) The
proportional representation of Bacteroides taxa
in unmanipulated culture collections installed
in gnotobiotic mice does not differ significantly
as a function of the diet embodiments animals
were fed. Means ± SEM for data generated from
feces are shown (n = 5 to 6 per group; one-way
ANOVA). (C) Schematic illustrating the different
groups of gnotobiotic mice generated by manipulating the presence/absence of ETBF and
NTBF within the stunted/underweight or healthy
donors’ culture collections and the questions addressed by the indicated comparisons. (D) Removal of ETBF prevents weight loss in mice
colonized with the stunted/underweight donor’s
culture collection. In contrast, addition of ETBF
with the simultaneous removal of NTBF does
not significantly affect weight in mice colonized
with the culture collection derived from the
healthy child (n = 5 to 6 mice per treatment
group). Means ± SEM are plotted. *P < 0.05
(paired two-tailed Student’s t test and linear
mixed effects model as above). (E) Addition of
NTBF to the stunted/underweight donor’s culture
collection ameliorates ETBF-associated weight
loss in gnotobiotic mice fed embodiment 2 of
a representative Bangladeshi diet (n = 6 mice
per treatment group). Means ± SEM are plotted.
*P < 0.05 (paired two-tailed Student’s t test and
linear mixed effects model as above).
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The effects of intraspecific interactions on microbial
gene expression.
We performed microbial RNA sequencing (RNA-seq) of cecal contents
harvested at killing to characterize the transcriptomes of members of the
unmanipulated and manipulated versions of the healthy and stunted
communities. Our goal was to assess (i) the effects of intraspecific competition (NTBF on ETBF and vice versa) in the healthy and stunted
community contexts, (ii) the effects of the cultured stunted/underweight
versus healthy donor community on ETBF, and (iii) the effects of
cocolonization with ETBF on other bacterial members (including other
Bacteroides). ETBF genes with significant differential expression attributable to the presence or absence of NTBF, in both healthy and stunted
community contexts, are listed in table S8 (B and F). Conversely, NTBF
genes with significant differential expression attributable to the presence
or absence of ETBF, in both healthy and stunted community contexts,
are highlighted in table S8 (C and E).
Fragipain is a cysteine protease that activates fragilysin by removing
its autoinhibitory prodomain. In mouse models of colitis, host proteases
can also serve this function, but fragipain is required for sepsis to occur
(23, 24). In the presence of NTBF, ETBF expression of fragilysin (bft-3)
in the cecal metatranscriptome of mice harboring the manipulated
ETBF(+) NTBF(+) healthy donor’s community was significantly decreased compared to the manipulated version of the community where
ETBF, but not NTBF, was present (39-fold, based on normalized
transcript counts; P = 0.002, one-tailed Student’s t test). Fragipain expression was also significantly reduced (14.2-fold; P = 0.0005, one-tailed
Student’s t test) (table S8B). In the context of the stunted community, the
reduction in bft-3 expression associated with introducing NTBF was
considerably more modest (5.9-fold; P = 0.09, one-tailed Student’s t test),
whereas fragipain expression was not significantly different between the
two treatment groups (P > 0.5, one-tailed Student’s t test; table S8).
When we abrogated fragilysin (bft-3) expression through insertional
mutagenesis (fig. S2), the mutant Dbft-3 strain grew robustly in vitro.
However, when germfree mice were gavaged with a manipulated version of the stunted donor’s culture collection containing this isogenic
strain with a disrupted bft-3 locus substituted for the wild-type ETBF
strain, we observed no detectable colonization of the mutant (n = 5 mice
fed diet embodiment 2 for 14 days); the number of COPRO-Seq reads
mapping to the mutant Dbft-3 strain was no greater than background,
and a PCR assay that used B. fragilis–specific bft primers was negative.
However, these results led us to conclude that this locus functions as
an important colonization factor for this particular ETBF strain in this
community context. However, these experiments did not allow us to
directly address the hypothesis that attenuation of bft-3 expression
produced by inclusion of NTBF in the stunted community contributed
to the observed mitigation of weight loss.
Looking beyond the effects of intraspecific interactions on btf-3 expression, we compared the cecal metatranscriptomes of gnotobiotic
mice colonized with the unmanipulated NTBF(+) ETBF(−) healthy
donor’s culture collection versus mice harboring the two manipulated
versions where ETBF was added, with or without removal of the two
NTBF strains. The results revealed that ETBF in the absence of NTBF
produced significant alterations in the expression of a number of transcripts related to various features of stress responses in several community members [Enterococcus faecalis, E. gallinarum, B. breve, and two
members of Enterobacteriaceae; differentially expressed genes identified
using the Robinson and Smyth exact negative binomial test (25), with
Bonferroni correction for multiple hypotheses] (Fig. 3). Both rpoS,
which is a key general stress response sigma factor that positively
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gavage and subsequently maintained on this diet for 14 days until they
were killed (n = 5 singly caged animals per treatment group, maintained in separate gnotobiotic isolators). Fecal samples were collected
at the time points described in fig. S1D.
Weight phenotypes.
Removal of the ETBF strain from the stunted/underweight donor’s
culture collection prevented the transmissible weight loss phenotype
(Fig. 2D; P = 5.9 × 10−8, two-tailed Student’s t test, comparison of
weights at killing). However, addition of the ETBF strain to the healthy
donor’s culture collection did not produce significant weight loss, regardless of whether the NTBF strains were present or absent (P = 0.3
and P = 0.2, respectively, two-tailed Student’s t test, comparison of
weights at killing; Fig. 2D). On the basis of these findings, we concluded
that whether ETBF produces weight loss (cachexia) is dependent on microbial community context.
COPRO-Seq analysis of the fecal microbiota of recipients of the unmanipulated ETBF(−) NTBF(+) healthy donor’s culture collection revealed that it contained the two NTBF strains [total relative abundance
of 14.5 ± 3.0% (mean ± SEM), with B. fragilis hVEW46 and B. fragilis
hVEW47 comprising 1.1 and 13.5%, respectively], two other Bacteroides
(B. thetaiotaomicron and B. caccae), plus Bifidobacterium breve and
Enterococcus. The relative abundance of B. fragilis was not significantly
different between mice harboring the transplanted unmanipulated
healthy donor’s culture collection and its two manipulated ETBF(+)
NTBF(−) and ETBF(+) NTBF(+) versions (P > 0.5, two-tailed Student’s t test; Fig. 2A). (The term “unmanipulated” indicates that all bacterial isolates that comprise a culture collection were pooled before
transplantation, whereas “manipulated” refers to the inclusion and/
or exclusion of B. fragilis strains as part of the gavaged consortium.)
The fecal microbiota of recipients of the unmanipulated stunted donor’s
culture collection was dominated by ETBF (relative abundance, 62.3 ±
4.0%). Removal of ETBF led to significant increases in the relative abundances of B. breve, another Bifidobacterium strain, Enterococcus lactis, and
Enterococcus gallinarum (P < 0.02, two-tailed Student’s t test; Fig. 2A).
To determine whether NTBF alone is sufficient to protect mice from
ETBF’s cachectic effects, we colonized three groups of C57BL/6 male
gnotobiotic mice, each with a different version of the stunted donor’s
culture collection: the unmanipulated culture collection containing
ETBF alone or one of two manipulated versions, one with NTBF alone,
and the other with both ETBF and NTBF strains. Mice were placed on
diet embodiment 2 for 2 days before gavage and maintained on this diet
for 2 weeks until killed (n = 6 animals per treatment group, all singly
caged; one treatment group per gnotobiotic isolator; fig. S1D). We observed a significant difference in weight phenotypes between mice colonized with the unmanipulated undernourished donor’s ETBF(+)
NTBF(−) culture collection compared to the manipulated ETBF(−)
NTBF(+) version (P = 0.01, one-tailed Student’s t test; Fig. 2E). Addition
of NTBF [yielding the ETBF(+) NTBF(+) community] markedly ameliorated the weight loss phenotype (P = 0.0004 for weights at killing
compared to mice with the unmanipulated community, one-tailed Student’s t test; Fig. 2E). Follow-up COPRO-Seq analysis revealed that the
relative abundances of ETBF at the conclusion of the experiment were
38.9 ± 3.9% and 39.0 ± 3.5% when animals were colonized with and
without NTBF, respectively. Thus, NTBF does not appear to mediate
its effects by reducing the fractional representation of ETBF in the community. However, ETBF appears to reduce the relative abundance of
NTBF, which constituted 41.8 ± 3.2% of the total community when
ETBF was absent but only 19.2 ± 2.6% when ETBF was present (P =
0.04, one-tailed Student’s t test).
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Strain

Healthy
ETBF(–)
NTBF(+)

ETBF(+)
NTBF(–)

Stress response
RNA polymerase σ factor RpoS
ATP-dependent RecD-like DNA helicase
HTH-type transcriptional regulator YjiE
Iron acquisition and metabolism
Sensor protein BasS
Ferric aerobactin receptor precursor
Ferric uptake regulation protein
Aerobactin synthase
Prophage and mobile DNA element

Integrase core domain protein

Prophage CP4-57 integrase
Putative prophage CPS-53 integrase
Transposase IS116/IS110/IS902
family protein
Transposase IS66 family protein
Transposase, mutator family
viral (superfamily 1) RNA helicase
Strain
Enterococcus faecalis hVEW36
Bifidobacterium breve hVEW45
Enterobacteriaceae hVEW34
Enterobacteriaceae hVEW33
Enterococcus gallinarum hVEW37

Z score

3

2

1

0

−1

Fig. 3. The effects of intraspecific NTBF-ETBF interactions on the community
metatranscriptome. Adult mice were colonized with the indicated unmanipulated
and manipulated versions of the healthy donor’s culture collection. All treatment
groups were monotonously fed diet embodiment 2. Cecal contents were collected
at the time of killing 14 days after initial colonization, and gene expression in the community was analyzed by microbial RNA-Seq. Each column represents data from an individual mouse. Each row represents the levels of a given transcript, normalized across
that row. Addition of ETBF to and removal of NTBF from the healthy donor’s culture
collection (middle set of columns) produced an increase in expression of the indicated
genes in strains whose identity is denoted by the color code on the left, compared to
their expression in the unmanipulated ETBF(−) NTBF(+) version (left set of columns) or
the manipulated version where the NTBF strains were retained when ETBF was added
(right set of columns). UniProt-based annotations are shown on the right. ATP, adenosine
triphosphate; HTH, helix-turn-helix.

controls expression of genes involved in transport of carbon sources and
iron acquisition, and recD, which is involved in DNA repair, exhibited
significant increases in their expression in the setting of ETBF without
NTBF (P < 0.05). Several genes involved in the acquisition and metabolism of iron were either up-regulated in the presence of ETBF (for example, ferric aerobactin receptor, ferric uptake regulation protein, and
aerobactin synthase) or repressed (for example, an Enterobacteriaceae
strain hVEW34 homolog of the Escherichia coli BasSR system component BasS, which is normally induced under high-iron conditions)
Wagner et al., Sci. Transl. Med. 8, 366ra164 (2016)

23 November 2016

79

7 of 14

Downloaded from http://stm.sciencemag.org/ on March 16, 2017

(26). ETBF’s effect on expression of these latter genes was mitigated
when NTBF was present (Fig. 3), highlighting the importance of iron
in intraspecific and interspecific interactions in the healthy donor’s consortium of transplanted cultured bacterial strains. In contrast, the presence or absence of ETBF or NTBF did not evoke significant changes in
the expression of these or other genes involved in iron metabolism in
the context of the stunted/underweight donor’s community. Numerous
genes related to prophage and mobile DNA element biology were also
expressed at significantly higher levels by healthy community members
when ETBF was present in the absence of NTBF (P < 0.05; Fig. 3). Prophage activation occurs in response to stress. Some studies have postulated that phage induction can “shuffle” community structure to favor
an increased proportion of pathobionts (27).
Studies in gnotobiotic mice have shown that signaling by members
of the human gut microbiota involving the quorum sensing molecule,
autoinducer-2 (AI-2), can alter virulence factor expression in enteropathogens (28) and have linked AI-2 signaling to modulation of the
levels of Bacteroidetes in the gut (29). LuxQ is involved in the detection
of AI-2. In the context of the healthy community, expression of three of
the four luxQ homologs in the ETBF genome was decreased when
NTBF was present [log2(fold change) of −2.8, −4.4, and −9.5, P <
0.005, exact negative binomial test; table S8B]. Comparing the mice
colonized with the unmanipulated ETBF(−) NTBF(+) and manipulated
ETBF(+) NTBF(+) versions of the healthy donor’s culture collection
revealed differential regulation of five other luxQ transcripts encoded by
Bacteroides members (three in B. thetaiotaomicron hVEW3, and two in
B. caccae hVEW51; table S8D). In the context of the stunted donor’s
community, the presence of ETBF had no significant effects on lux gene
expression in NTBF or any other community members, nor did the
presence of NTBF have any effect on lux expression in ETBF (table S8, E
and F). Together, these results illustrate the importance of community
context in determining the transcriptional effects of intraspecific (and
interspecific) interactions involving ETBF.
Metabolism.
The metabolic effects of manipulating the representation of ETBF and
NTBF in the healthy and stunted donor’s communities were studied by
targeted mass spectrometry (MS) of tissue samples obtained from mice
in the fed state (table S7). Quantifying amino acids, organic acids, acylcarnitines, and acyl-CoAs in livers obtained from animals colonized
with either of the two unmanipulated culture collections disclosed that
compared to mice harboring the healthy donor’s ETBF(−) NTBF(+)
culture collection, those colonized with the stunted donor’s ETBF(+)
NTBF(−) culture collection had higher concentrations of propionylCoA and isovaleryl-CoA [by-products of oxidation of branched-chain
and other amino acids; P < 0.05, false discovery rate (FDR)–adjusted
two-tailed Student’s t test; Fig. 4A], and lower concentrations of acetylCoA (P = 0.07) and its cognate metabolite acetyl carnitine (that is, C2
acylcarnitine; P = 0.001; Fig. 4B). Mirroring these trends, cecal contents
harvested at the time of killing from mice harboring the stunted donor’s
unmanipulated culture collection contained higher concentrations of
branched-chain amino acids (P = 0.066 for isoleucine/leucine and P =
0.1 for valine) and lower concentrations of acetyl-carnitine (P = 0.067).
However, these trends were not observed in skeletal muscle.
Acetyl-CoA and acetyl-carnitine are generated by glucose, fatty acid,
or amino acid metabolism, with a primary contribution from glucose
metabolism in the fed state. A deficit in these metabolite pools suggests
impaired flux of glucose to acetyl-CoA in mice with the stunted compared
to healthy donor’s unmanipulated culture collection. The decline in acetylCoA and acetyl-carnitine levels occurred in concert with significant
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NTBF(+)
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Fig. 4. Host metabolic abnormalities associated with the stunted donor’s community. Mice were colonized with
Gut barrier/immune function.
the indicated culture collections and fed diet embodiment 2. Animals were killed 21 days after colonization, and metabolites
One view of the effects of B. fragilis enin their livers were quantified by mass spectrometry (n = 5 to 6 mice per treatment group). Means ± SEM are plotted. Altered
terotoxin is that it perturbs gut barrier
concentrations of acyl-CoAs (A), acylcarnitines (B), and organic acids (C) in the livers of mice colonized with the unmanipulated
function, increasing permeability via
ETBF(+) NTBF(−) stunted donor’s culture collection versus animals harboring the unmanipulated ETBF(−) NTBF(+) healthy
cleavage of E-cadherin (11), triggering
donor’s culture collection provide evidence for metabolic dysfunction involving the TCA cycle and mitochondrial fatty acid
the release of proinflammatory cytokines
oxidation in the former group. (D) ETBF in the setting of the unmanipulated stunted donor’s community is associated with
including tumor necrosis factor–a (TNF-a)
greater hepatic concentrations of the d18:1/16:0 ceramide known to inhibit mitochondrial oxidative metabolism compared
to manipulated versions of the culture collection where ETBF has been removed with or without replacement by NTBF or
(30), and augmenting b-catenin signaling
when NTBF and ETBF are both present. *P < 0.05 (two-tailed Student’s t test).
(31). Treatment of chow-fed, conventionally raised mice with antibiotics followed
increases in hepatic levels of the late tricarboxylic acid (TCA) cycle by introduction of wild-type NTBF, NTBF with an engineered active bft
intermediates malate and fumarate (P < 0.005 compared to mice with allele, wild-type ETBF with an active bft allele, or ETBF with a Dbft1
the healthy donor’s culture collection; Fig. 4C), as well as a trend toward allele revealed that under these conditions, bft was necessary to produce
increased succinate (P = 0.1). These patterns were again mirrored in the colitis (32). Small-scale human studies have demonstrated a greater
cecum but not in skeletal muscle. Early-stage TCA cycle intermediates representation of ETBF in individuals with active inflammatory
citrate and a-ketoglutarate were not different across these groups. Con- bowel disease (33) and colorectal cancer (34). Strains harboring bft-3
versely, and consistent with impaired glucose availability or metabo- have been reported to generate less biologically active toxin than strains
lism, lactate concentrations were significantly lower in the livers of having bft-1 or bft-2 alleles (22).
mice colonized with the stunted donor’s culture collection (P = 0.002;
Analyses of hematoxylin and eosin–stained sections of small intesFig. 4C), with an associated decrease in cecal lactate concentrations (P = tine and colon obtained from mice consuming the representative
0.0005; table S7B). Hepatic pyruvate also showed a downtrend (P = 0.16; Bangladeshi diet and colonized with either of the two unmanipulated
table S7B).
culture collections or two manipulated versions [ETBF(−) NTBF(−)
Combining the acyl-CoA and organic acid data, this metabolic stunted or ETBF(+) NTBF(+) healthy] revealed no hallmarks of inflamprofile is consistent with a scenario in which mice colonized with the mation, such as an overabundance of neutrophils in the gut mucosa,
unmanipulated ETBF-containing stunted donor’s culture collection crypt hyperproliferation or loss, or loss/damage of villi in the small inhave decreased capacity for metabolism of glucose to acetyl-CoA. It testine (n = 5 mice examined per treatment group).
appears that these animals attempt to compensate by an increase in
We performed a follow-up flow cytometry analysis of immune cell
amino acid metabolism that is sufficient to produce enough acetyl- populations in the colon, and mesenteric lymph nodes of four groups
CoA to maintain normal citrate and a-ketoglutarate levels. However, of mice: those colonized with the stunted donor’s culture collection
use of these fuels also creates substrates that lead to production of distal with or without ETBF and those harboring the unmanipulated
TCA cycle intermediates (anaplerosis), for example, via propionyl-CoA healthy donor’s culture collection or its manipulated ETBF(+) NTBF(−)
conversion to succinate, and aspartate conversion to oxaloacetate, fu- version. Consistent with a previous study of specified pathogen-free
marate, and malate.
mice treated with antibiotics to boost colonization with an ETBF isolate
Comparing mice colonized with the unmanipulated stunted donor’s (34), colonic T helper 17 (TH17) cell populations (TCR-b+CD4+CD8a−
culture collection versus the manipulated ETBF(−) NTBF(−) version of IL-17A+) were significantly increased in animals colonized with mathe stunted donor’s culture collection revealed that removal of ETBF nipulated ETBF(+) NTBF(−) healthy and unmanipulated ETBF(+)
6
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biotic mouse studies emphasize that microbiota community context
also needs to be considered when understanding the potential effects
of this and other enteropathogens (39). The approach described in
this report should help shed light on this issue. Constructing communities from culture collections captures a donor’s history of microbial
exposures in their places of residency, as well as the evolutionary events
that have shaped the genetic features of the gut strains they harbor.
Culture collections generated from healthy and undernourished donors
from this or other populations can be introduced into young rapidly
growing animals (either through direct gavage or maternal transmission), or into adult animals, to better understand how intraspecific
and interspecific interactions with one or more enteropathogens affect
host biology in specified and/or systematically manipulated dietary and
microbial community settings. A limitation of the present study is that
the microbiota dissection was limited to two donors from a small cohort
of 100 children. An obvious next step is to address the generalizability of
our findings; this can be accomplished in a variety of ways, including
analyses of the effects of introducing different ETBF and NTBF strains
recovered from other Bangladeshi donors into the existing culture
collections, as well as culture collections generated from individuals representing other populations.
An intriguing difference transmitted by the healthy and undernourished donor’s culture collections involves the host metabolic
phenotype. On the basis of our findings, we propose that the limited
rate of acetyl-CoA production in mice receiving the stunted donor’s
culture collection cannot keep pace with the increased influx of substrates that replenish TCA cycle intermediates (anaplerosis), explaining
the increase in distal TCA cycle substrates. At a more global level,
increased oxidation of amino acids to maintain a minimal acetyl-CoA
pool may divert amino acids away from protein synthesis, contributing
to a wasting phenotype. Furthermore, concentrations of amino acids
were modestly but consistently lower in the sera of mice colonized with
the culture collection from the stunted compared to the healthy donor.
This is consistent with use of amino acids for anaplerosis, thereby contributing to lower amino acid supplies for host growth and metabolism.
Some bacterial members of the gut microbiota contain the complete
enzymatic apparatus for executing the TCA reaction sequence. The
finding that there is marked inhibition of the distal TCA cycle in harvested cecal contents and liver but not skeletal muscle leads to the following testable hypotheses: (i) interactions between the undernourished
donor’s microbiota and dietary components yield products that are
present at high-enough levels to inhibit the TCA cycle in community
members; (ii) these products are transported from the gut by the portal
circulation in sufficient quantities to inhibit the TCA cycle in hepatocytes; (iii) either first-pass metabolism of these products by the liver or
other processes limit their levels in the systemic circulation so that their
effects on the TCA cycle are not observed in muscle; and (iv) TCA cycle
inhibition negatively affects the ability to harvest energy from an already
impoverished diet.
In our previous study of Malawian twins discordant for severe acute
malnutrition, 1H nuclear magnetic resonance analyses of urine obtained
from adult gnotobiotic mice colonized with intact uncultured microbiota indicated that TCA cycle inhibition was a feature of animals
harboring the undernourished co-twin’s microbiota and consuming
a macronutrient- and micronutrient-deficient prototypic Malawian diet.
These animals but not their counterparts that had been colonized with
the healthy co-twin’s microbiota exhibited a pronounced diet-dependent
weight loss phenotype that did not occur in the context of a macronutrientand micronutrient-sufficient diet (7). Together, these findings suggest

DISCUSSION

The question of what determines the effects of a large enteropathogen
burden in children at risk for undernutrition, or with already overt
disease, is rooted in the definition of “pathogen”—both conceptually
and operationally. Koch’s postulates invoke the requirement for an
isolated candidate pathogen to produce a disease when introduced into
a host species, without necessarily considering the microbial ecology of
the body habitat that the organism invades and establishes itself. The
approach described in this study, involving generation of sequenced,
clonally arrayed culture collections from the fecal microbiota of healthy
and stunted/underweight Bangladeshi children and subsequent introduction of these consortia, with or without addition or subtraction of
ETBF and NTBF strains, into germfree mice fed embodiments of the
diets consumed by the microbiota donors, allowed us to characterize
how B. fragilis functions as a pathobiont in a microbial community
context-dependent manner.
A topic of interest to those studying the pathogenesis of undernutrition is the relative effects of enteropathogen burden in nondiarrheal fecal samples and the presence or absence of environmental
enteric dysfunction, an enigmatic disorder associated with populations
where sanitation is poor and enteropathogen burden is high (38). Although ETBF itself was not correlated with stunting in our small study
cohort of 100 children, additional studies in larger populations coupled
with quantitative PCR assays for other enterpathogens are needed to
ascertain the contributions of ETBF to disease. Results from our gnotoWagner et al., Sci. Transl. Med. 8, 366ra164 (2016)
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NTBF(−) stunted culture collections compared to the unmanipulated
ETBF(−) NTBF(+) healthy and manipulated ETBF(−) NTBF(−)
stunted culture collections (P < 0.001 and P < 0.02, respectively, Student’s t test; fig. S3, A and B). The presence of ETBF was not associated
with significant differences in the size of the anti-inflammatory FoxP3+
regulatory T cell population in mesenteric lymph nodes in either the
stunted/underweight or healthy community contexts (P > 0.05, Student’s
t test; fig. S3C).
B. fragilis polysaccharide A (PSA) is the product of one of the organism’s capsular polysaccharide synthesis (CPS) loci. A number of studies
have shown that PSA functions as an immunomodulatory factor mitigating inflammatory responses in the gut via its effects on reducing interleukin17 (IL-17) and inducing FoxP3+ regulatory T cells (35, 36). Microbial
RNA-seq disclosed that the expression of genes in this CPS locus (37)
was not significantly different in the ETBF and NTBF strains as a function
of community context (unmanipulated versions of the healthy or stunted
donor consortia) or engineered intraspecific interactions (table S8B).
We expanded our analysis to examine the effects of intraspecific
interactions on serum cytokine profiles in three groups of mice: those
harboring the unmanipulated stunted donor’s culture collection and
those colonized with the manipulated ETBF(+) NTBF(+) and EBTF(−)
NTBF(+) versions. ETBF(+) NTBF(−) mice had significantly higher
levels of the proinflammatory cytokines IL-17A, TNF-a, and interferon-g
compared to ETBF(−) NTBF(+) mice (P = 0.02, P = 0.03, and P = 0.03,
respectively; one-tailed Student’s t test) (fig. S3D). However, these effects
were not reversed with NTBF cocolonization (P > 0.05 for all comparisons) despite NTBF’s protective effect with respect to weight loss, leading
us to postulate that (i) the weight loss phenotype was a reflection, at least
in part, of the combined effects of disturbances in central metabolism
and subtle perturbations in gut barrier function, and (ii) other members
of the undernourished donor’s transplanted culture collection, besides
ETBF, were contributors to these abnormalities.
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MATERIALS AND METHODS

Human study design
Samples were obtained from an already completed observational
birth cohort study (Field Studies of Human Immunity to Amebiasis in
Bangladesh) (14). The study was conducted using protocols for obtaining informed consent, clinical samples, and clinical metadata that were
approved by institutional review boards from the International Centre
for Diarrhoeal Disease Research, Bangladesh (icddr,b) (study ID number 2007-041), the University of Virginia, Charlottesville (study ID
number 7563), and Washington University in St. Louis (study ID number
201111065). Fecal specimens used in this study were covered by a
material transfer agreement between icddr,b and Washington University
in St. Louis. Fecal samples from 100 of the 147 children enrolled in this
study were used for the analysis described in the current report; this number was not based on a previous power calculation derived from knowledge
of ETBF carriage rate but rather represented samples from individuals
who had been surveyed during the second year of postnatal life.

Clonally arrayed bacterial culture collections
Collections of cultured anaerobic bacterial strains were generated from
frozen fecal samples according to previously published methods (20, 21).
Cultures were arrayed in 384-well plates in Coy Chambers under strict
anaerobic conditions (77% N2, 20% CO, and 3% H2) using a Precision
XS liquid handling robot (BioTek). Bacteria isolates occupying each well
were first grouped into 100% ID OTUs on the basis of the results of V416S rRNA amplicon sequencing. Most OTUs were observed more than
once across an arrayed library. Next, three to four isolates representing
each OTU were picked robotically from the 384-well arrays and struck
out individually onto eight-well agar plates containing GMM (20).
DNA from isolates was subjected to whole-genome shotgun sequencing
using an Illumina HiSeq 2000 instrument (101-nt paired-end reads) or
a MiSeq machine (150-nt paired-end reads). Sequences were assembled
using MIRA (41) version 4.02 (parameters: “-NW:cnfs = warn, −NW:
cmrnl = no, −GE:not = 4”; template_size = “150 500 autorefine”). Coverage of isolate genomes from the severely stunted/underweight donor’s
culture collection was 38.6- ± 5.0-fold (mean ± SEM) with an N50 contig
length of 28.5 ± 3.5 kb (mean ± SEM) (table S3B). The corresponding
values for members of the healthy donor’s collection are described in
(21). Genes were annotated using Prokka (v1.10) (42). Predicted genes
in each isolate’s genome assemblies were mapped to KEGG pathways
and assigned KEGG Ortholog groups by querying the KEGG reference
database (release 72.1) (BLAST 2.2.29+, blastp E value ≤10−10, single best
hit defined by E value and bit score). Putative virulence factors were identified using the Virulence Factor Database [(43); BLAST hits with E value
<10−17 bearing UniProt database annotations].
Full-length 16S rRNA gene amplicons were generated from isolates
using primers 8F and 1391R. Isolates sharing ≥99% nucleotide sequence
identity in their 16S rRNA genes and ≥96% sequence identity throughout
their genomes as determined by NUCmer (44) were defined as representing a unique strain. Full-length 16S rRNA sequences were used to define
taxonomy [Ribosomal Database Project (RDP) version 2.4 classifier (45)].
Clonally arrayed, sequenced culture collections were stored in GMM/15%
glycerol at 80°C in 96-well plates (TPP Tissue Culture Test Plates).
Generation of a bft-3:pGERM mutant in the ETBF strain
cultured from the stunted donor’s microbiota.
Disruption of the bft-3 gene was accomplished using the Bacteroides
suicide vector pGERM. A 380–base pair (bp) fragment of the 5′ end of

bft PCR assay
DNA isolated from fecal samples collected at 18 and 24 months of age
from members of the birth cohort was used for a bft PCR assay using
primer pairs 5′-GAACCTAAAACGGTATATGT-3′ (GBF-201) and 5′GTTGTAGACATCCCACTGGC-3′ (GBF-210) (40), OneTaq 2× Master
Mix (New England Biolabs) and the following thermocycling conditions:
after initial melting at 95°C for 30 s, 30 cycles of 95°C for 30 s, 53°C for
30 s, and 68°C for 30 s, with a final annealing time of 7 min at 68°C.
Testing fecal samples for parasites
A clinical microscopy–based screen for Entamoeba histolytica, Entamoeba
dispar, Blastocystis hominis, Trichomonas hominis, coccidian-like bodies,
Giardia lamblia, Ascaris lumbricoides, Trichuris trichiura, Ancylostoma duodenale/Necator americanus, Hymenolepsis nana, Endolimax
nana, Iodamoeba butschlii, and Chilomastix mesnili was also performed
on these fecal samples, as reported in (5).
Preparation of human fecal samples for transplantation to
germfree mice
Aliquots (1 g) of previously frozen fecal samples were resuspended
under anaerobic conditions (77% N2, 20% CO, and 3%H2) in 15 ml of
gut microbiota medium (GMM) (20) and homogenized at a setting of
“high” in a sterilized blender (Waring). Homogenates were clarified by
passage through 100-mm–pore-diameter nylon filters (BD Falcon). Five
milliliters of sterile 2-mm-diameter glass beads was added, and remaining cell clumps were disrupted by vortexing (four on/off cycles, each for
30 s). A final filtration through a 40-mm–pore-diameter nylon filter (BD
Falcon) was performed before storage in GMM containing glycerol
[final concentration of 15% (v/v)] at −80°C in 2-ml amber glass vials
with a crimp-top butyl septum (Wheaton Scientific).
Preparation of Bangladeshi diet embodiments
Diet embodiments with ingredient and nutritional contents described
in table S2 were prepared in 15-kg batches. Tilapia fish fillets (Whole
Foods Markets) were simmered for 30 min in a 20-liter stainless steel
Wagner et al., Sci. Transl. Med. 8, 366ra164 (2016)
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pot over a Corning hot plate (temperature set at “4”). Fruits and vegetables were combined and simmered in a separate pot for 45 min on a
Corning hot plate (temperature set at “4”). Parboiled rice (Delta Star)
was cooked in a rice cooker (KRUPS). Lentils were simmered for 90 min
(temperature set at “2”). All ingredients for a given diet embodiment
were combined in a vertical cutter-mixer (Robot Coupe Model R23)
and pureed for 5 min. Aliquots were cooled in large plastic containers
for 12 hours at 4°C. Aliquots (500 g) were then vacuum-sealed in 8 ×
10–inch plastic bags (Uline). The vacuum-sealed food paste was placed
in a second 8 × 10–inch plastic bag (as an added barrier against incidental contamination), and the contents of the packages were sterilized by
irradiation (20 to 50 kGy) within 24 hours of food production (Steris
Co.). Sterility was verified by culturing samples of the irradiated diet in
brain heart infusion (BHI) medium for 5 days at 37°C under anaerobic
and aerobic conditions (21). In addition, B. subtilis spore strips that had
been included along with the food during the irradiation were cultured
under the same conditions. Final nutritional profiles were obtained for
samples of each embodiment (Nestlé Purina Analytical Laboratories, St.
Louis, MO).

that metabolic studies of serum, urine, and feces obtained from children before, during, and after treatment for their undernutrition
should include quantitative assessment of analytes linked to TCA
cycle activity.
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bft-3 was introduced into Bam H1–digested pGERM using the Gibson
Assembly Cloning Kit (New England Biolabs). Primers to create the
PCR product for the Gibson reaction were created using the NEBuilder
Assembly Tool (v1.7.2). Assembled constructs were introduced by electroporation into kanamycin-resistant, electrocompetent E. coli DH5-a
RK231 (46). Transformants were plated on LB agar containing
isopropyl-b-D-thiogalactopyranoside/X-gal (Sigma-Aldrich) and ampicillin (100 mg/ml). Individual colonies were picked and grown in LB medium plus ampicillin; successful transformation was verified by PCR. The
pGERM-transformed E. coli DH5-a RK231 and the ETBF strain (isolate
mB11 of strain B. fragilis mVEW4) were conjugated by filter-mating on
BHI-blood agar plates incubated under anaerobic conditions at 37°C for
24 hours. Bacterial cells from the resulting lawn were collected by
scraping and plated on BHI agar containing erythromycin/gentamicin
(25 and 100 mg/ml, respectively). Plates were incubated under anaerobic
conditions at 37°C for 48 hours. Picked colonies were sequenced to confirm successful pGERM insertion into bft-3, and positive colonies were
stored in tryptone yeast glucose (TYG) containing 15% (v/v) glycerol.
The mutant and wild-type strains were cultured at 37°C under
anaerobic conditions in TYG liquid medium to mid-log phase. Cells
were then harvested, and RNA was extracted using TRIzol reagent (Life
Technologies). To confirm that bft expression had been disrupted,
complementary DNA (cDNA) was generated from the extracted RNA
(see RNA-seq section below) and used as a template for a PCR-based
assay that used ReddyMix PCR Master Mix (Thermo Fisher Scientific),
a forward primer that spans the vector insertion site (5′-ATGAAGAATGTAAAGTTACTTTTAATGCTAGGAACCG-3′), a reverse
primer 3′ to the crossover site (5′-CTCCACTTTGTACTTTATACTACTGAATATGCTTG-3′), and the following cycling conditions:
94°C for 10 min followed by 30 cycles of 94°C for 30 s, 56°C for 30 s,
72°C for 60 s, with a final extension of 72°C for 5 min.

donor microbiota. Investigators were not blinded to either diet or microbiota treatments.
Feeding Bangladeshi diet embodiments was initiated 2 days before
colonization with either uncultured fecal microbiota samples or pools
generated from arrayed bacterial culture collections. Diets were extruded
as a paste from their plastic bags into food trays. Fresh 30-g aliquots of
the paste were provided to each singly caged animal per day. For
experiments where diet embodiments were changed, autoclaved Aspen
hardwood laboratory bedding (NEPCO) was replaced at the start of
each embodiment transition to minimize carryover of ingredients from
the preceding diet embodiment exposure.
For the intergenerational transmission experiments, male pups
(n = 3 to 4 for each intact donor microbiota and n = 5 for each culture
collection), representing the combined litter from trio matings were
weaned onto LF/HPP chow and transitioned to the Bangladeshi diet
embodiments at 8 weeks of age (embodiments 1→2→3; 10 days per
diet phase).

Assembling consortia of cultured bacterial strains
for gavage
Archived 96-well culture collection plates were thawed in an anaerobic
chamber and aliquots of each well inoculated into 600 ml of GMM in
96-deep-well culture plates (Thermo Fisher Scientific). Cultures
were grown anaerobically to stationary phase at 37°C, with growth
measured at OD600 (optical density at 600 nm). Equal amounts of
selected isolates (100 ml) were pooled using the Precision XS liquid
handling robot. For manipulations involving addition of NTBF, both
strains of the nontoxigenic strain were used. For manipulations involving
subtraction of the single ETBF strain or both NTBF strains, the strains
were simply excluded from the pooling step. Final pools were mixed 1:1
with sterile phosphate-buffered saline (PBS) plus glycerol (to achieve a
final concentration of 15%) and aliquots (1 ml) were placed in 2-ml
butyl septum-stoppered amber glass vials (Wheaton) for storage or
gavage into germfree animals.
Gnotobiotic mouse experiments
All mouse experiments were performed using protocols approved by
Washington University Animal Studies Committee. Before the initiation
of experiments, germfree adult male C57BL/6 mice were maintained in
plastic flexible film gnotobiotic isolators under a strict 12-hour light
cycle and fed an autoclaved LF/HPP chow ad libitum (B&K Universal,
diet 7378000). Different treatment groups (that is, mice gavaged with
different microbial communities) were maintained in separate gnotobiotic isolators. All animals studied were included in subsequent analyses.
Male mice were age- and weight- matched before gavage of human
Wagner et al., Sci. Transl. Med. 8, 366ra164 (2016)
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Characterizing microbial community composition and
gene expression
Multiplex sequencing of bacterial 16S rRNA PCR amplicons.
Genomic DNA was extracted from mouse fecal pellets using a phenolchloroform and beat-beating protocol (45). Bar-coded primers 515F
and 806R were used to generate PCR amplicons covering the V4 region
of bacterial 16S rRNA genes present in the samples. Multiplex sequencing of pooled amplicons with sample-specific bar codes was performed
using an Illumina MiSeq instrument (250-bp paired-end reads). Reads
were trimmed in silico to 200 bases to retain the highest-quality base
calls, assembled with FLASH (v1.2.11) and demultiplexed in QIIME
(v1.8.0) (21). The 16S rRNA sequence data sets were first analyzed using
open-reference OTU picking (97% ID OTUs) (uclust-ref against the
Greengenes reference database). Sequences (98.7% of the 26,419,497)
that passed QIIME’s default quality filters were successfully clustered
with a reference sequence of ≥97% identity. For all subsequent analyses,
OTU tables were rarefied to 4000 reads per sample and filtered to retain
only those OTUs whose relative abundances in fecal microbiota were
≥0.1% in ≥1% of all samples sequenced. Taxonomies were assigned
using RDP classifier 2.4 trained on the manually curated Greengenes
database “Isolated named strains 16S.”
COPRO-Seq of fecal samples collected from mice colonized
with unmanipulated and manipulated culture collections.
Unidirectional reads (75 nt) were generated from fecal DNA samples
using an Illumina MiSeq instrument and trimmed to 50 nt to preserve
the highest-quality reads before mapping onto the genomes of culture
community members. The analytic pipeline for COPRO-Seq is described
in (21) and uses software available at https://github.com/nmcnulty/
COPRO-Seq.
Microbial RNA-seq.
Procedures for performing microbial RNA-seq are detailed in previous
publications (21). Aliquots of cecal contents (~50 mg) that had been
collected at killing (14 dpg) and stored at −80°C were suspended in
500 ml of extraction buffer (200 mM NaCl and 20 mM EDTA), 210 ml
of 20% SDS, 500 ml of phenol/chloroform/isoamyl alcohol (pH 4.5,
125:24:1; Ambion/Life Technologies), and 150 ml of acid-washed glass
beads (212- to 300-mm diameter; Sigma-Aldrich). Cells were lysed by
mechanical disruption using a bead beater (maximum setting, 5 min at
room temperature; BioSpec Products), followed by phenol/chloroform/
isoamyl alcohol extraction and isopropanol precipitation on ice. After
treatment with ribonuclease (RNase)–free TURBO-DNase (Ambion/Life
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Intracellular cytokine staining was performed on cell suspensions
from mesenteric lymph nodes and colonic lamina propria after restimulation in round-bottom 96-well plates in complete RPMI containing
b-mercaptoethanol (0.05 mM; Sigma-Aldrich) supplemented with
phorbol 12-myristate 13-acetate (50 ng/ml; Sigma-Aldrich), ionomycin
(750 ng/ml; Sigma-Aldrich), and brefeldin A (eBioscience; diluted
according to the manufacturer’s recommendations). Cells were restimulated at 37°C for 3 hours in a humidified CO2 tissue culture incubator.
Cells in which FoxP3 was assessed were not restimulated.
Cell surface and intracellular staining was performed as described
previously (52) with the following two modifications: (i) cells were
washed free of excess protein from restimulation medium, or from the
HBSS/0.1% bovine serum albumin (BSA) (w/v) buffer, using HBSS
without BSA, and (ii) the incubation containing anti-CD16/CD32
[Fc block (2.4G2); BD Pharmingen] also included Live/Dead Fixable
Aqua Dead Cell Stain (Life Technologies) to allow identification and
removal of dead cells during the analysis that followed fixation and
permeabilization. Cells were stained with the following antibodies:
CD4 eFluor 450 (GK1.5, eBioscience), CD4 allophycocyanin (RM4-5,
BD Pharmingen), T cell receptor b (TCR-b) Alexa Fluor 488 (H57-597,
BioLegend), CD8a allophycocyanin (53-6.7, BioLegend), FoxP3 eFluor
450 (FJK-16s, eBioscience), and IL-17A phycoerythrin (TC11-18H10.1,
BioLegend). Appropriate isotype control antibodies were purchased
from the same vendors that supplied antibodies targeting molecules
of interest. Cells were analyzed with an Aria III flow cytometer (BD
Biosciences), and data were analyzed with FlowJo software (Tree Star;
version 7.6.1).

Mass spectrometry
Tissues previously stored at −80°C were weighed while frozen and
immediately homogenized in a solution of 50% aqueous acetonitrile/
0.3% formic acid (50 mg of tissue per milliliter solution; procedure done
at 4°C using an IKA T25 Ultra-Turrax High-Speed Homogenizer at
maximum setting for 30 to 45 s). Amino acids, acylcarnitines, organic
acids, acyl-CoAs, and ceramides were analyzed using stable isotope
dilution techniques. Amino acid and acylcarnitine measurements were
made by flow injection tandem MS using sample preparation methods
described previously (47, 48). Data were acquired using a Waters Acquity
UPLC system (Waters) equipped with a TQ (triple quadrupole) detector
and a data system controlled by the MassLynx 4.1 operating system
(Waters). Organic acids were quantified (49) using a Trace Ultra Gas
Chromatograph coupled to ISQ MS operating under Xcalibur 2.2
(Thermo Fisher Scientific). Acyl-CoAs were extracted and purified as
described previously (50), and analyzed by flow injection analysis using
positive electrospray ionization on a Xevo TQ-S, TQ mass spectrometer
(Waters). Heptadecanoyl CoA was used as an internal standard. Ceramides were extracted (51) and analyzed by flow injection tandem MS
using a Xevo TQS spectrometer (Waters).

Measurements of serum cytokine levels
Blood was collected via retro-orbital phlebotomy at the time of killing,
and derived serum samples were analyzed, alongside standards, using
the Bio-Plex Pro Mouse Cytokine 23-plex Assay (Bio-Rad) following
the manufacturer’s instructions. Technical duplicates were performed
for each sample.
Statistical analyses
Routine statistical analyses were performed in R (version 3.1.2). P < 0.05
was considered to be statistically significant. Specific statistical tests are
noted in the figure legends and throughout the text. Bonferroni correction for multiple hypotheses was applied to identify genes that exhibited
significant differences in their expression between treatment groups.

Histologic analysis
Intestines were harvested and placed in 10% neutral-buffered formalin
for 3 hours at room temperature, washed in 70% ethanol, prepared as
“Swiss rolls,” paraffin-embedded, and 5-mm-thick sections were cut.
Hematoxylin and eosin–stained sections were evaluated for alterations
in crypt number (evaluated by crypt density), crypt depth, villus height,
epithelial proliferation [measured by M-phase cells per crypt (n =
100 crypts per specimen evaluated) and neutrophils per crypt unit (n =
100 crypt units evaluated per specimen)]. All slides were blinded before
quantification.

SUPPLEMENTARY MATERIALS
www.sciencetranslationalmedicine.org/cgi/content/full/8/366/366ra164/DC1
Fig. S1. Experimental designs.
Fig. S2. Generation of a Dbft-3 strain of ETBF.
Fig. S3. Assessing the effects of ETBF on gut barrier/immune function.
Table S1. Summary of anthropometric scores and results of PCR assays for bft in the fecal
microbiota of members of a birth cohort of 100 Bangladeshi children.
Table S2. Composition and nutritional content of Bangladeshi diet embodiments, and
nutritional requirements of mice and children.
Table S3. V4-16S rRNA, COPRO-Seq, microbial RNA-seq, and cultured bacterial strain genome
sequencing data sets.
Table S4. Bacterial culture collection generated from the fecal microbiota of a severely stunted
Bangladeshi child.
Table S5. Genome features of isolates in the clonally arrayed bacterial culture collection
generated from the fecal microbiota of a severely stunted 2-year-old Bangladeshi child.
Table S6. Weights of all individual mice as a function of diet, microbiota, and dpg.
Table S7. MS-based quantitation of metabolites in host tissues, serum, and cecum obtained
from mice in the different treatment groups.
Table S8. Effects of intraspecific and interspecific interactions on ETBF, NTBF, and other
Bacteroides gene expression profiles in healthy or stunted donor community contexts.

Immune cell isolation and characterization
Cells from the spleen, mesenteric lymph node, and lamina propria of the
colon were isolated as described previously (52), with two minor modifications: (i) Hanks’ Balanced Salt Solution (HBSS) was used in place of
Dulbecco’s PBS, and (ii) collagenase type VIII (Sigma-Aldrich) was used
at a concentration of 0.1 mg/ml for isolation of colonic lamina propria cells.
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Technologies), MEGAlear columns (Life Technologies) were used to
remove 5S rRNA and transfer RNAs. A second deoxyribonuclease
(DNase) treatment (Baseline-Zero DNase, Epicentre/Illumina) was
performed before a second MEGAclear purification followed by rRNA
depletion (Ribo-Zero rRNA removal kits, Epicentre/Illumina). cDNA
was synthesized (SuperScript II, Invitrogen), and second-strand synthesis was performed with RNase H, E. coli DNA polymerase, and E. coli
DNA ligase (all from New England Biolabs). cDNA libraries were
prepared by shearing samples using a Bioruptor Pico sonicator (Diagenode), then size-selecting 150- to 200-bp fragments for blunting, Atailing, and ligating sample-specific barcoded sequencing adapters, and
finally PCR enrichment. cDNA libraries were pooled for multiplex
sequencing using an Illumina NextSeq instrument (13.4 ± 1.1 million
unidirectional 75-nt reads/cecal RNA sample), with the exception of the
sample IDs ETBF.expt.112-116 (table S3D), which were sequenced on
the MiSeq platform (6.6 ± 0.7 million unidirectional 75-nt reads per
sample). Identification of differentially expressed genes was performed
in R (version 3.2.3) using the Robinson and Smyth exact negative binomial test with Bonferroni correction (edgeR package, version 3.10.2) as
described previously (21).
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Neighbors matter
A big unanswered question is what determines the effects of enteropathogen burden in children
who are undernourished or at risk for undernutrition. In a new study, Wagner and colleagues introduce
collections of sequenced gut bacterial strains cultured from healthy or underweight Bangladeshi
children into germfree mice fed diets resembling those consumed by the children. The gut bacterial
strains were transplanted with or without nontoxigenic or enterotoxigenic Bacteroides fragilis strains.
Addition of enterotoxigenic B. fragilis induced cachexia in the transplanted mice, and altered gene
expression and metabolic activity of the transplanted bacterial strains. These effects were mitigated by
cocolonization with nontoxigenic B. fragilis, illustrating the influence of intra- and interspecies
interactions in determining the impact of an enteropathogen on its host.
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REVIEWS
Going viral: next-generation
sequencing applied to phage
populations in the human gut
Alejandro Reyes1, Nicholas P. Semenkovich1, Katrine Whiteson2, Forest Rohwer2
and Jeffrey I. Gordon1

Abstract | Over the past decade, researchers have begun to characterize viral diversity using
metagenomic methods. These studies have shown that viruses, the majority of which infect
bacteria, are probably the most genetically diverse components of the biosphere. Here, we
briefly review the incipient rise of a phage biology renaissance, which has been catalysed by
advances in next-generation sequencing. We explore how work characterizing phage
diversity and lifestyles in the human gut is changing our view of ourselves as supra-organisms.
Finally, we discuss how a renewed appreciation of phage dynamics may yield new
applications for phage therapies designed to manipulate the structure and functions of
our gut microbiomes.

CRISPRs
(Clustered regularly
interspaced short palindromic
repeats). Widespread genetic
systems in bacteria and
archaea, consisting of multiple
copies of palindromic repeats
flanking short spacers of viral
or plasmid origin. CRISPR
elements provide acquired
resistance to foreign DNA.
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From Alfred Hershey and Martha Chase’s studies indicating that DNA is the genetic material1, to Francis Crick
and Sydney Brenner’s experiment establishing the triplet
nature of the genetic code2, viruses that infect bacteria
(referred to below as phages) have helped define the fundamental components of modern biology. Most of the
tools for early molecular biology arose from the work
of phage biologists3. The first genomes sequenced were
from phages and other viruses, and the first comparisons of multiple genomes were carried out on phages
of Lactobacillus and Mycobacterium spp. These early
studies showed that there is extensive diversity in essentially every phage community. It is now clear that viruses
are the most diverse and uncharacterized components
of the major ecosystems on Earth4 and have intricate
roles in ecosystem function that go far beyond simple
predator–prey dynamics5 (BOX 1).
The clinical world has become increasingly interested in phage-based therapeutics because of the
increased prevalence of antibiotic-resistant bacteria6. The idea of using phages as therapeutic tools is
not new. Félix d’Herelle, the co-discoverer of phages,
recognized their potential medical applications nearly
a century ago 7, and his first phage therapies were
tested as early as 1919 (REF. 8). However, our thenrudimentary understanding of the composition and
dynamic operations of the human microbiome, our
lack of knowledge of phage biology, and poor quality
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control during phage production made this therapeutic
approach unreliable9.
In this Review, we detail recent advances in the rising
field of viral metagenomics, with an emphasis on our
current views of the phage communities associated with
the human gut. We do not discuss many of the mechanisms of resistance to phages, such as CRISPRs (clustered
regularly interspaced short palindromic repeats), or the
extremely large field of eukaryotic virus discovery, which
is being propelled by metagenomics, as these topics have
been reviewed elsewhere10–14. Instead, we focus exclusively on viruses that infect bacteria. There are many
challenges facing phage metagenomics at the present
time, several of which are discussed below; some of the
technical improvements that are required to overcome
these challenges are outlined in BOX 2.

Methods for viral metagenomics
The introduction of small subunit (SSU) rRNA — that
is, 16S rRNA — as a reliable bacterial and archaeal
phylogenetic marker 15–17 allowed remarkable insights to
be gained about the diversity and dynamics of microbial communities. Phylogenetic-marker ‘envy’ rapidly
‘infected’ the psyche of phage biologists: they did not
have an SSU rRNA equivalent, and there was (and still is)
no conserved protein or gene enabling a similar characterization of all or even the majority of phages present in
a sample. Efforts to characterize phage diversity focused
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Box 1 | Phage–bacterial host dynamics: lessons learned from environmental ecosystems
Most of life on Earth exists as bacteria and archaea in oceans, sediments, land and the deep biosphere112. In the early
1980s, researchers became aware that there are literally millions of actively growing microorganisms per millilitre of sea
water, and efforts to characterize the impact of phage life cycles on planetary-scale biogeochemistry were initiated113–116.
As an example of how dramatic the effects of phages can be, consider the widespread cyanobacterial clades
Prochlorococcus and Synechococcus. The species in these two genera of unicellular algae carry out about half of the
primary production in the world’s oceans; these bacteria are also infected with cyanophages, and variations in cyanophage
and bacterial concentrations are tied to daily and seasonal cycles115. The isolation and characterization of phages infecting
Synechococcus|URR KPVJGU CPFProchlorococus|URR KPVJGU TGXGCNGFPQVQPN[VJCVE[CPQRJCIGUCTG
widespread, often infecting 40–50% of cyanobacteria, but also that they kill 10–50% of their hosts daily114,115, rapidly
driving the diversification of their hosts as these bacteria co-evolve resistance117, and simultaneously driving carbon into
a dissolved form when bacterial cells lyse. When levels of available resources are low, cyanophages can enter a lysogenic
state. A growing list of genes that are important for bacterial host metabolism and function have been found in marine
phages, including photosystem genes that can increase the host’s photosynthetic output and maintain energy
production during infection so that phages can eventually lyse their host cells51,118–120. Lysogeny may be an important
lifestyle under a number of suboptimal conditions, including when host abundance or nutrient abundance is low121.
Bacteria can use temperate phages to enable invasion of new habitats. When part of the bacterial population is
sacrificed through phage lysis, the released phages will target competitors but allow bacterial kin harbouring the
prophages to survive, as they are resistant to attack owing to a process called superinfection exclusion122–125.
The concept that a virus can have a beneficial effect beyond that experienced directly by its host cell is not novel.
Three-way symbioses have been well described in macro- and micro-ecosystems. For example, a symbiotic bacterium
that inhabits the pea aphid protects the aphid from a wasp that can otherwise lay eggs in the aphid haemocoel; this
protection is conferred by a phage-encoded toxin expressed by the bacterium126,127. Drought, heat and cold tolerance are
conferred to plants through viruses122,128. In Yellowstone National Park, USA, a fungal endophyte infecting panic grass
confers thermal tolerance, allowing the grass to grow in hot geothermal soils; however, the fungus is not heat tolerant
without the virus that infects it129. In a phage-related example, there is a reported case of phage-associated corynetoxin
synthesis in the bacterium Rathayibacter toxicus HQTOGTN[Clavibacter toxicus YJKEJEQNQPK\GUT[GITCUURNCPVUVJGVQZKP
makes the grass toxic to grazing animals such as sheep130.

Virus-like particles
(VLPs). Particles that can be
recovered from microbial
communities using physical
separation methods such as
density gradient ultracentrifugation and/or filtration. Purified
VLPs have physical
characteristics that resemble
those of viruses, although their
capacity for infection has to be
subsequently defined.

Virotype
A taxonomic classification that
is typically based on a selected
percentage identity threshold
among viral reads, rather than
on phylogenetic markers.

Multiple displacement
amplification
A method for exponential
isothermal amplification of a
DNA template using
φ29 DNA polymerase and
random primers. Exponential
amplification is achieved by
attachment of the polymerase
to newly elongated fragments,
coupled with the strong
displacement activity of the
enzyme on extension.

Deep biosphere
The deepest oceanic regions in
which life is supported.

on partially conserved fragments of phage genes such as
those encoding polymerases. However, this method was
useful only within certain viral families18–20. Horizontal
gene transfer further complicates the use of marker genes
in phages. For example, most members of the order
Caudovirales have identifiable conserved genes, including those encoding terminases, portal proteins and
capsid proteins, but horizontal transfer and recombination events generate extensive genome mosaicism that
challenges phylogenetic characterization21. The arrival
of next-generation sequencing, together with methods
for purifying virus-like particles (VLPs), set the stage for
defining viral diversity using shotgun sequencing.
Purification of VLPs. Although viruses outnumber
microbial cells 10:1 in most environments, viral DNA
represents 2–5% of the total DNA in a microbial community 22–24. For this reason, it is often desirable to
separate viruses from microbial cells. If the sample
volume is large and the viral density low (such as in
ocean environments), tangential flow filtration can
be used to recover and concentrate VLPs. For solid
samples with a high viral density, such as faeces, a
common approach is to resuspend the material in an
osmotically neutral buffer, followed by one or more
steps designed to remove large particles, including
undigested or partially digested food fragments and
microbial cells, by caesium chloride density gradient ultracentrifugation 25 and subsequent filtration
(FIG. 1). This procedure has been successfully applied to
faecal material that has been stored at −80 °C for several years, without any pre-processing of the sample,
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indicating that VLP structures are stable under conditions
of freezing and thawing 22.
Amplification of VLP-derived DNA. After VLPs are purified, non-encapsulated free nucleic acids are removed
by treatment with DNase and RNase, and VLP-derived
nucleic acids are then isolated. The methods chosen
determine the purity of the DNA and RNA, influence the
DNA and RNA yields, and represent a selection step that
can bias the subsequent interpretation of virotype abundance and viral community diversity26. Unfortunately, the
yield of DNA following extraction of nucleic acids from
purified VLPs is often below the required minimum for
sequencing. Therefore, a range of amplification methods
have been developed, such as random amplified shotgun
library (RASL)27 and linker-amplified shotgun library
(LASL)28, among others29–32. Caveats concerning random
PCR amplification of viral DNA include an uneven coverage of viral genomes, the limitation of this approach to
double-stranded DNA (dsDNA) templates, and an inherent bias attributable to the exponential amplification of
mixed templates. Another common method uses the
phage-derived φ29 polymerase for multiple displacement
amplification (MDA)33. MDA takes advantage of the high
processivity of this DNA polymerase (>70,000 nucleotides
(nt) per association–dissociation cycle) and its strong
strand displacement capability, which together permit the
amplification of complete viral genomes. The result is a
fast method that can efficiently amplify minute amounts
of both single-stranded DNA (ssDNA) and dsDNA.
Although the method is fast, it is not without flaws,
including the overamplification of small circular ssDNA
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Box 2 | Technical challenges in viral metagenomics
r0GYCPFDGVVGTVQQNUHQTVJGTGEQXGT[QHXKTWUNKMGRCTVKENGU 8.2U HTQOUOCNNCOQWPVUQHUVCTVKPIOKETQDKCNEQOOWPKV[
biomass, and methods for less biased amplification of extracted nucleic acids before shotgun sequencing.
rImproved methods for deep-draft assemblies of full-length viral genomes. Particularly problematic are the ends of
phage genomes, which can be blocked or permuted or can have hairpins.
r6JGCWVQOCVKQPQHOGVJQFU HQTGZCORNG/CZK2JK HQTECTT[KPIQWVEQORCTCVKXGOGVCIGPQOKEUCPFGUVKOCVKPI
α-diversity, β-diversity and γ-diversity, in order to describe the pan-virome in a given environment.
rNew and better tools for defining the host specificity of known and novel phages from either assembled genomes or
8.2FGTKXGFUJQTVTGCFUGSWGPEGUCPFHQTKFGPVKH[KPIVJGFGVGTOKPCPVUQHOKETQDKCNJQUVEGNNTCPIG
rImproved methods of experimentally and computationally assigning functions to ‘conserved’ viral genes with no known
HWPEVKQPU UJGFFKPINKIJVQPVJGnIGPGVKEFCTMOCVVGToVJCVKUTGRTGUGPVGFD[EQPUGTXGFJ[RQVJGVKECNIGPGU 
rBetter KP|XKVTQ and KP|XKXQ models for determining phage–bacterial host dynamics and the impact of these interactions
on energy availability and niche partitioning in a microbiota.
rExperimental and computational methods, and related visualization tools, for efficient analyses of temporal variation in
model microbial communities, and for measuring the effects of perturbations.
rModels for predicting the cost or benefit of having prophage present in a candidate probiotic species; for example,
weighing invasiveness and persistence in a targeted microbiota.
rMethods to test the utility of phages to directly perturb a targeted microbiota in ways that facilitate invasion by a
probiotic species or species consortium.

viruses34 and the potential formation of chimaeras35,36.
Procedures for avoiding some of these limitations continue to be developed37,38, including a novel transposonbased method for rapidly generating DNA libraries
from small quantities of dsDNA39. RNA viruses can be
sequenced by reverse transcription followed by application of the protocols described above. Alternatively,
whole-transcriptome amplification approaches can
be used40.

Prophages
Temperate phages in a
host-incorporated state.

α-diversity
Diversity, whether defined
using taxonomic or functional
characteristics, within a
particular locale (habitat) at a
particular moment in time.

β-diversity
Diversity measured between
samples or locales at a
particular moment in time or
over time.

γ-diversity
A combination of alpha and
beta diversity.

Sequencing strategies. Although sequencing costs are
falling at an astonishingly rapid rate as newer technologies offer higher degrees of parallelism (that is, greater
numbers of reads per run, and multiplex sequencing
using sample-specific DNA bar-codes), read length
matters41. When characterizing a viral community from
which most of the sequences are novel and enriched in
regions of low-complexity repeats, obtaining the longest
possible reads will aid accurate assembly and taxonomic
assignment41,42. The earliest next-generation sequencing analyses were powered by the 454 GS20 instrument (from Roche) with ~100 nt reads. Advances in
pyrosequencing technology, including today’s 454 FLX+
machine, have produced average read lengths that exceed
800 nt22,23,43–46. Most recently, total microbial-community
DNAs have been subjected to deep shotgun sequencing
with more highly parallel Illumina instruments; analyses
of the resulting metagenomic data sets have shown that
the percentage of reads with similarity to known viral
sequences is generally less than 0.01%30,47,48. This low
value is in part due to the short read length (≤100 nt).
However, the percentage of similarity increases when
VLPs are purified32. Other studies have obtained better
assignments by assembling the short reads49,50.
In summary, researchers engaged in viral metagenomic studies have tended to opt for technologies that
prioritize long read lengths over those that offer short
read lengths but higher throughput. However, as the
high-throughput platforms approach 150 nt read lengths
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and 250 million reads per lane (such as the Illumina
HiSeq 1500 and 2500 instruments), and as the cost per
read falls, we will undoubtedly see a rapid transition to
these types of sequencers — so long as improvements in
assembly algorithms keep pace (FIG. 1).
Computational approaches for characterizing sequenced
viromes. To address the question of viral community
composition, shotgun metagenomic sequences are typically compared to individual viral genomes. Although
public sequence databases have expanded considerably
— from 500 viral genomes in 2007 to more than 3,000
full viral genomes in 2012 — the number of deposited
genomes is far less than the expected number of virotypes present in 100 litres of sea water 51. Compounding
this problem, existing databases include few viral proteins in their training sets, meaning that many taxonomic assignments are based on proteins that have
been transferred from a virus to a microbial host or
that are present in prophages and are described as part
of a microbial genome. Databases with a particular
focus on viruses are under development and include A
Classification of Mobile Genetic Elements (ACLAME)52
and Phage SEED53. Novel data analysis pipelines are also
being constructed to improve the accuracy and efficiency of homology searches (see REFS 54–59, and Phage
SEED and Virome).
When taxonomic and functional assignments have
been made for a given sample, a viral community profile
can be created that characterizes the diversity present in
that sample. Multidimensional reduction methods such
as principal component analysis (PCA) and hierarchical
clustering have been used to visualize similarities among
viral communities, and methods such as supervised
learning can help to identify discriminatory features.
Given that most of the available viral metagenomic
data lack similarity to entries in databases, similarityindependent methods have been developed to better
understand viral community structure. One example,
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should be given to the assembly parameters in order to
prevent mixed assemblies and chimaeras between viral
genomes (FIG. 1).

Experimental methods
Frozen faecal sample
r 2assage through . m
and .22 m diameter Ȯlters
r &ensity gradient
ultracentrifugation
r 2recipitation with
polyethylene glycol
r 0uclease treatment

V.2 puriȮcation
and concentration
Quality control
measures
r /icroscopy
Sybr)reen staining
for assessment
of the purity of V.2s
Quality control
measures
r 1S rR0A gene and
1S rR0A gene 2%R
for contaminants

r /ultiple displacement
ampliȮcation /&A
r .inker ampliȮed shotgun
library .AS.
r Random ampliȮed shotgun
library RAS.

&0A extraction
and ampliȮcation

&0A sequencing
multiplexing with
sample-speciȮc
bar-codes

r  pyrosequencing
F.: Titanium or F.:
r Illumina sequencing
HiSeq or /iSeq

Computational methods
Quality control measures
r Filter out exact repeats
and sequencing errors
r Screen against
contaminating host
human or mouse &0A
sequences

%lassiȮcation
of reads by
bar-codes

Assembly
r &iscovery and
annotation of viral
contigs and genomes
Similarity-independent
analysis
r 0ucleotide frequencies
r Sequence clustering or
cross-assembly using the
2HA%%S, /axi2hi or
crAss algorithm
r &etermination of
_- and `-diversity

Similarity-dependent analysis
r 3uery public and custom
databases ViralArefseq,
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2hage SEE&
r Importance of search
algorithms, similarity
thresholds and order
of comparisons

Figure 1 | Experimental and computational methods for the characterization of
the phage populations present in the human gut microbiota. See main text for
further details. VLP, virus-like particle.

Pan-genome
The global gene repertoire of
a microbial species; defined by
sequencing the genomes of
isolates of that species
obtained from a single or
multiple habitats.

Bacterial phylotypes
Taxonomic classifications that
are based on phylogenetic
markers, classically the 16S
rRNA gene. Isolates can be
arbitrarily assigned to a
species-level phylotype if they
share ≥97% sequence identity
among their 16S rRNA genes.

PHACCS (Phage Communities from Contig Spectrum),
was designed to quantify virotypes60,61 on the basis of the
assumption that if a virotype is present in high abundance in a VLP sample, it is more likely to be assembled into a large contig. Moreover, we can posit that if
assembly of a single sample data set allows prediction
of community structure and diversity, then pooling two
samples together and carrying out a cross-assembly
analysis could determine the inter-sample diversity
(by, for example, using MaxiPhi62). Another alternative
for identifying shared viruses among different samples comes from crAss, an algorithm that allows for
the simultaneous cross-assembly of all the samples in
a data set as opposed to the pairwise assemblies used in
MaxiPhi. As more tools are developed, special attention
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Phages in the human gut
The gut provides an exciting place to characterize the
role of phages in community assembly and dynamics.
Assembly of the human gut microbiota begins at birth,
with evolution towards an adult-like configuration during the first 3 years of life63. The importance of early environmental exposures is emphasized by the fact that the
overall phylogenetic composition of the gut microbiota
is not significantly more similar in adult monozygotic
twins than in dizygotic twins, and the fact that family
members have a higher degree of similarity in the gut
microbiota than unrelated individuals living in different
households. These patterns are robust to different cultural traditions, and the observations about mono- versus
dizygotic twins apply to children as well as teenagers and
adults63,64. Microorganisms in this densely populated ecosystem are engaged in a constant fight for nutrients and
survival. Peristalsis moves an ephemeral menu of dietary
components along the cephalocaudal axis of the intestine, and the microbial inhabitants face the omnipresent
threat of washout from the gut ‘bioreactor’. Maintaining
a foothold in this ecosystem depends not only on physical interactions with the perpetually renewing mucous
layer and partially digested food particles, but also on
functional interactions with other community members.
Preserving functional redundancy contributes to community resilience, and horizontal gene transfer provides
an opportunity to constantly modify the pan-genome of a
given species-level bacterial phylotype. Each adult appears
to harbour a persistent collection of one hundred, or at
most a few hundred, species in their intestines, although
strain level diversity is great24,65,66. Although the proportional representation of taxa changes as the community
responds to various environmental perturbations, intrapersonal variation in species content is considerably less
than interpersonal differences63,64,67,68.
As our knowledge of inter- and intrapersonal variations in the microbiota has increased, a lagging question
has been the role of phages in shaping the properties
of these microbial communities. Although a number
of individual phages have been extensively characterized, providing an important genomic context against
which metagenomic data can be interpreted, recently
more attention has been given to phage dynamics at
the microbial community level. In 2003, the first report
of a human-associated gut virome was published; it
described the results of shotgun Sanger sequencing of
DNA from VLPs isolated from a faecal sample obtained
from a single healthy adult. The identifiable fraction of
the virome was dominated by phages, including temperate phages. This report estimated that there were
1,200 different virotypes in the single sample analysed,
with the majority assigned to the Siphoviridae family 28.
Siphoviridae and temperate phages have subsequently
been reported to be the most abundant identifiable
viruses in other sampled faecal viromes, followed by
members of the family Podoviridae22,23,69.

92
© 2012 Macmillan Publishers Limited. All rights reserved

www.nature.com/reviews/micro

F O C U S O N N E X T- G E N E R AT I O N S E Q U
NG
RE N
VC
I EIW
S

93

The prominence of members of the family
Microviridae in adult human gut microbiota was initially dismissed as an artefact of the MDA method,
which has a preference for ssDNA. However, a novel
branch of the family Microviridae has been identified recently, from prophages present in the genomes
of Bacteroides and Prevotella spp.70. These two genera are prominently represented in the microbiota of
adult human populations living in a number of diverse
geographical areas63,71. Another study characterizing
Microviridae members from healthy human donors
also clustered these novel viruses with prophages from
Bacteroides and Prevotella spp.69. These analyses suggest that Microviridae is an important viral family
in the human gut, and also that what was previously
considered to be an exclusively lytic phage can in fact
integrate into bacterial hosts in an environment that
encourages a temperate (lysogenic) virus–host lifestyle
(see FIG. 2 and below).
Marine environments can contain millions of different virotypes in a single sample51. By comparison, none
of the human faecal samples characterized thus far has
had more than 1,500 virotypes. Moreover, the ratio of
virotypes to species-level bacterial phylotypes is 10:1

in the ocean but closer to 1:1 in the gut 22. Microscopy
counts have further validated these estimated ratios,
demonstrating an average of 108–109 VLPs per gram of
faeces compared with ~109 bacterial cells per gram69.
These findings also support the notion that phages
exhibit a more temperate lifestyle in the gut, in contrast
to the active kill-the-winner virus–bacterial host dynamic
manifest in marine environments.
The temperate lifestyle of phages observed in the
gut, along with bacterial CRISPR elements involved in
conferring immunity to infection with foreign DNA
(including phages), has facilitated bioinformatic efforts
to discover new phages in this body habitat. Recently,
data sets obtained from deep shotgun sequencing of
human faecal-community DNA24 were used to extract
CRISPR spacers present in gut bacterial genomes 72.
These spacers were then used to query data sets of shotgun sequencing reads from faecal VLP-derived DNA22,23,
and contigs assembled from total faecal-community
DNA24. This approach allowed a large collection of these
previously unassigned contigs to be designated as viral
and assigned to potential bacterial hosts. This study also
led to an appreciation of the wide distribution of novel
phages across human gut communities.
r Protection against superinfection
r Expansion of the bacterial host’s niche by
r Enhanced carbohydrate utilization
a
r Antibiotic resistance
Lysogeny
r Production of toxins
r /odiȮcation of host gene expression

r Mobilization of genes (HGT)
r Pressure on host for diversiȮcation
of the phage receptor

c

Infection

b

Lysis

Lysogenic
Pertaining to a temperate
phage: a state in which linear
(1:1) replication is achieved
through integration of the
phage genome into the
chromosome of the bacterial
host (or, more rarely, the phage
exists as a plasmid within the
host cell). The integrated
phage transcribes genes that
repress lytic action, and in
some cases expresses genes
that promote the fitness of the
bacterial host.

Kill-the-winner virus–
bacterial host dynamic
A model for the population
dynamics of phage–bacterium
interactions; this model
postulates that an increase in a
host population (the winner) is
followed by an increase in its
corresponding phage predator,
resulting in an increase in the
rate at which the winner is
killed.

r Constant-diversity dynamics
r Destruction of niche competitors
r ‘Phage shunt’ and bacterial turnover

Figure 2 | Potential consequences of a temperate phage life cycle in the human gut. Metagenomic studies of viruses
suggest that a temperate lifestyle is dominant in the distal human gut, in contrast to the the lytic lifestyle observed in open
oceans. This temperate lifestyle can have benefits for the phage and the bacterial host, and can alter phage–host dynamics.
Integration as a prophage (part a) protects the host from superinfection, effectively ‘immunizing’ the bacterial host against
infection from the same or a closely related phage. Furthermore, the genes encoded by the phage genome may expand the
niche of the bacterial host by enabling metabolism of new nutrient sources (for example, carbohydrates), providing
antibiotic resistance, conveying virulence factors or altering host gene expression. This temperate (lysogenic) life cycle
allows phage expansion in a 1:1 ratio with the bacterial host. If the prophage conveys increased fitness to its bacterial host,
there will be an increased prevalence of the host and phage in the microbiota. Induction of a lytic cycle (part b) can follow a
lysogenic state and can be triggered by environmental stress. As a consequence, bacterial turnover is accelerated and
energy utilization is optimized through a ‘phage shunt’, in which the debris remaining after lysis is used as a nutrient source
by the surviving bacterial population. Furthermore, a bacterial subpopulation that undergoes lytic induction sweeps away
other sensitive species and increases the niche for survivors (that is, bacteria that already have the specific phage integrated
into their genome). Periodic induction of prophages can also lead to a constant-diversity dynamic139, which helps maintain
community structure and functional efficiency. Novel infections or infections of novel bacterial hosts by phages (part c)
bring the benefit of horizontally transferred genes and create selective pressure on the hosts for diversification of their
phage receptors, which are often involved in carbohydrate utilization. HGT, horizontal gene transfer.
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Temporal variation. To date, only three reported
metagenomic studies of the human gut virome have
characterized temporal variation22,23,73. One of these
studies used VLPs that were isolated from frozen faecal
samples collected from four adult female monozygotic
twin pairs and their mothers at three time points over a
12-month period22. VLP-derived virome data sets were
compared to data sets of both sequenced bacterial 16S
rRNA genes, and shotgun reads from total faecal-community DNA generated from the same faecal samples
used to prepare the VLPs. The results disclosed that the
viromes of co-twins and their mothers exhibited a significantly greater degree of interpersonal variation than
did the corresponding bacterial communities. Despite
the marked interpersonal variation in gut viromes and
their encoded gene functions, intrapersonal diversity
was extremely low: >95% of virotypes were retained
over the period surveyed, and DNA viromes were
dominated by a few temperate phages that exhibited
remarkable genetic stability (>99% sequence conservation). These observations suggest that a temperate viral
lifestyle is more prevalent in the distal intestine than a
kill-the-winner dynamic (see FIG. 2).
Another study of temporal variation involved adults
who were subjected to a defined diet for a period of
8 days23. During this time, both bacterial and viral faecal communities changed in a comparable manner.
Importantly, interpersonal variation at the late time
points was reduced among individuals consuming the
same diet, suggesting that diet has an important effect
in shaping both bacterial and viral components of the
microbiota.
A third study examining temporal variation characterized the DNA virome of a 1-week-old healthy infant
and used DNA microarrays to compare relative viral
abundances in the faecal microbiota between postnatal
week one and two73. The results showed that the viral
population changes drastically in the early stages of
human life: more than half of the virotypes that were
present at week one were undetectable by week two.
Although these findings contrast with the stability of the
DNA viromes in healthy adult faeces, they are consistent
with the dynamic and rapid nature of assembly of the
infant bacterial microbiota63,74.
Functions encoded in phage genomes. There are a number of examples of known phage-encoded host fitness
factors in gut bacteria (for example, the phage λ lipoprotein Bor and outer-membrane protein Lom, and
the phage 933W Shiga-like toxin 2 (SLT2; also known
as Stx2 (REFS 75,76)), but most of these appear to be
virulence determinants of one kind or another. When
comparing purified VLP-derived viromes and faecal
microbiomes in the study of monozygotic twins, phages
have been shown to exhibited enrichment for genes
involved in anaerobic nucleotide synthesis, as well as
cell wall biosynthesis and degradation22. Other distinctive features of phage genomes include genes that can
alter bacterial phage-receptors and prevent superinfection77. Interestingly, many phage receptors may be
involved in carbohydrate transport and utilization. In an
612 | SEPTEMBER 2012 | VOLUME 10

environment such as the gut, where carbohydrate utilization is an important fitness factor, mobilization of these
bacterial genes by phages could endow bacterial hosts
with benefits (FIG. 2). There are probably a great number
of bona fide metabolic and other fitness factors that have
yet to be characterized which are encoded by phages.
Intriguingly, new evidence suggests that carbohydrate-binding components of the human gut virome can
change at an extremely high rate. A recent metagenomic
study examining VLPs purified from faecal samples
collected from 12 humans identified 51 hypervariable
loci — areas with mutation rates that are much higher
than those for the rest of the viral genomes50. Structural
predictions for proteins putatively encoded by these
regions revealed little homology to known folds; however, some of these proteins have similarity to immunoglobulin superfamily domains, and others to C-type
lectin domains that participate in carbohydrate binding.
Moreover, these loci appear to be specifically targeted
for mutation by a reverse transcriptase-based mechanism, suggesting that a crucial functional advantage is
provided by these hypervariable loci. It is tempting to
speculate that these loci confer a selective advantage
to phages, enabling immune evasion through immunoglobulin A (IgA) binding, or improving the chances
of infecting a host cell in the rapidly changing conditions of the gut through adaptable binding to relevant
environmental materials or bacterial surface receptors.
There is a well-documented precedent for this scenario: hypervariable loci confer a fitness advantage in
phages that infect Bordetella spp., as they allow tropism
switching in the phage receptor-binding protein78. The
hypothesis that these loci allow a phage to bind IgA or
environmental ligands is speculative and needs experimental validation; non-receptor structural phage proteins have been found to contain Ig-like domains, which
may aid in host binding by weakly interacting with the
cell surface79.
RNA virome. The RNA virome of two healthy adults has
been characterized by purifying and sequencing the RNA
from VLPs80. In this study, most RNA viruses appeared
to be consumed together with food. Indeed, a pepperassociated virus (pepper mild mottle virus) constituted
more than 80% of the identifiable gut viruses. The only
animal-infecting RNA virus observed was a picobirnavirus that had previously been found in the faeces of
healthy individuals as well as in the faeces of patients
with diarrhoea; this virus has not been associated with
any particular disease to date.

Comparative studies of other mammals
Comparative studies of different mammalian species
represent a source of information about the effects of
environmental factors, including diet 81,82, and various
host factors on phage diversity in the gastrointestinal
tract. Extensive surveys have been conducted of viruses
associated with different mammalian species, with the
aim of finding potential sources of zoonoses, uncovering the aetiology of animal diseases and identifying
common mammalian viruses13. These studies, which
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Box 3 | Characterizing the eukaryotic virome in the gut of healthy individuals
The eukaryotic virome can be considered from at least three different perspectives:
viruses associated with the eukaryotic component of the gut microbiota, viruses
associated with various human cell populations exposed to this microbiota, and viruses
associated with ingested food. Metagenomic studies of faecal microbial communities
from healthy individuals indicate that these communities are dominated by phages
rather than eukaryotic DNA viruses22,23,28,50,69,73. Eukaryotic RNA viruses are abundant but
appear to be largely derived from food80.
Our view of the eukaryotic virome in the gut comes largely from metagenomic studies
of patients with various gastrointestinal diseases131–137. These studies have identified
MPQYPGPVGTKEXKTWUGU CFGPQXKTWUGUTQVCXKTWUGUGPVGTQXKTWUGUCPFPQTQXKTWUGU CPF
novel members of the Bocavirus, Picobirnavirus and Cosavirus genera and of the family
Anelloviridae that are potential human pathogens, as well as novel viruses that may be
TGNCVGFVQFKGV OGODGTUQHVJGIGPWU)[TQXKTWUCPFQHVJGHCOKNKGUNodaviridae,
Dicistroviridae, Virgaviridae and Partitiviridae 6JGJKIJRTGXCNGPEGQHUKPINGUVTCPFGF
eukaryotic DNA viruses in metagenomic data sets has led to a new perspective on the
potential importance and diversity of these small viruses138. Although these viruses
were initially identified in symptomatic individuals, they have also been identified, at a
similar prevalence, in asymptomatic contacts of individuals with disease. The broad
representation of these eukaryotic viruses in the human gut as well as in other body
habitats has prompted a call to consider the functional significance of the human
eukaryotic virome12. The almost ubiquitous presence of human viruses that are not
phages and have not been associated with any disease indicates that viruses, especially
those acquired in early childhood, might be essential for proper immune system
development and that particular host genotypes or immunological constraints might
cause normally benign viruses to induce disease states.

Coliphages
Phages that infect coliform
bacteria, in particular
Escherichia coli.

include surveys of mammals occupying distinct habitats29,31,32,83–88, identified viruses from certain families
in the human gut virome, further underscoring the
prevalence and long-standing nature of the evolved
virus–mammalian host relationship (BOX 3). In all these
studies, ssDNA viruses were found to be ubiquitous and
accompanied in some cases by positive-sense ssRNA
enteric viruses43,87,88.
An early survey of coliphages in cows, pigs and
humans89 showed that these phages are present in titres
of up to 107 VLPs per gram of faeces and that temperate
coliphages are the most common. Interestingly, humans
and pigs (omnivores with simple guts) had higher counts
of temperate coliphages than cows (herbivores with foregut fermentation chambers). In an independent study,
estimates of phage diversity from bovine rumen fluid90
suggested that up to 28,000 different virotypes can be present in titres as high as 109 VLPs per millilitre of sample,
hinting at a strikingly higher viral diversity and abundance in the cow gut than in the human gut. In contrast
to the large interpersonal variation observed in human
gut viromes22,23, this latter study demonstrated a high
degree of similarity between the phage communities of
co-habiting animals on a similar diet. Metagenomic studies in horses83 (herbivores with a hindgut fermentation
chamber) revealed an intermediate level of phage diversity between that documented in herbivorous foregutfermenting ruminants and omnivorous mammals with
simple guts.
Together, these studies suggest that diet, gut physiology and potentially the transit time of food all have
important roles in determining the life cycle and diversity
of phages in the mammalian gut. Further dissection of
these relationships requires manipulable, representative
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and defined in vivo models. Moving in this direction,
Maura and colleagues used mice to study the effects of
a lytic enteric phage, observing stable long-term phage
replication over 3 weeks91. As noted below, gnotobiotic
mouse models might also be very informative.

Phage therapy
Much has already been written about the history, successes and failures of phage therapy. Most of the studies to date have focused on the use of lytic phages to
destroy pathogenic bacteria92,93 (FIG. 3). Clinically oriented phage research began soon after the discovery of
phages, when Félix d’Herelle used phages to treat bacillary dysentery in a number of human patients8. However,
this optimistic start led to several misconceptions and
missteps, both scientific and political, regarding the use
of phages. d’Herelle incorrectly assumed that there was
only one universally efficacious strain of lytic phage94,
although we now know that phages exhibit exquisite host
cell specificity. In the 1930s, pharmaceutical companies
began distributing enormous amounts of lytic phages as
generic antibacterial therapies, but in part because of the
perceived universality of phages, they had little knowledge
of the components of these products.
In retrospect, we know that many of the commonly
used phage preparations were destroyed by the organomercury preservatives added to the vials that contained
the preparations, or were contaminated with bacterial
exotoxins secreted by the cultures used to generate the
phages95. Inevitably, these problems, along with manufacturing inconsistencies (the supposedly standardized
strains of phages would change from batch to batch), led
to distrust among the medical and scientific community.
The recent resurgence of phages as possible therapeutic agents has been driven by a number of factors.
The alarming prevalence of antibiotic-resistant strains
of pathogenic bacteria, combined with the inexorable
spread of antibiotic-degrading enzymes, such as New
Delhi metallo-β-lactamase (NDM1), have led to calls for
new therapeutic strategies96. From a practical standpoint,
efforts in antibiotic discovery have produced few novel
compounds over the past decade97. Phages are promising
tools because they are easy to manufacture, have good
host specificity and can be genetically manipulated.
Moreover, resistance to phages may develop more slowly
than resistance to antibiotics, although the reasons for
this are multifaceted98. Phage resistance can occur spontaneously in cultures (as frequently as 1 in 105 cells), but
there can be fitness costs associated with resistance. By
contrast, many forms of antibiotic resistance cannot
occur spontaneously but instead require the introduction of a foreign DNA element. In many ways, addressing bacterial resistance is much easier with phages than
with antibiotics because one can isolate different phages,
or the phage may spontaneously mutate to overcome
host resistance.
Perhaps a more interesting question, in the context of
community dynamics and our growing understanding
of the virome and microbiome, is whether we can produce more subtle phenotypic shifts in an ecological niche.
Rather than using phages to destroy a single pathogenic
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A purely lytic phage forces
clonal selection, leading
to rapid resistance to
the phage

a

b

Synergistic eȭects from
antibiotics and phages
lead to less resistance
+ Antibiotic

c

Lysogenic
phage with
a nutrient
biosynthesis
gene

BeneȮts for the human
host harbouring the gut
microbiome

Lysogenic phage
with a gene that
allows digestion
of dietary glycans

Pathogenic bacterium
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A more resilient
community resists
colonization by pathogens

Phage receptors

Figure 3 | Potential strategies for phage therapy. a|||The traditional strategy for phage therapy has been to use a lytic
phage that targets pathogenic bacteria. Although this approach is transiently useful, it can lead to rapid bacterial
resistance owing the resultant positive selection for subpopulations (clones) that are resistant to the lytic phage. Note
that this is an antiquated approach to phage therapy and can be trivially improved by using multiple phages with
non-overlapping host resistance patterns or by selecting for phage mutants that overcome host resistance. b|||More
recently, the synergistic relationships between phages and antibiotics have been exploited, with the use of lysogenic
phages that do not kill the pathogen when used alone but instead decrease its survival when used in concert with
antibiotics. An example is a phage that inhibits a DNA damage repair system (the SOS response), thus rendering the host
bacterium exquisitely sensitive to quinolone class antibiotics140. c|||With our growing understanding of the human
microbiome, it may be possible to take a more nuanced approach, selectively manipulating (that is, enhancing) microbial
community functions or clearing the way for invasion by probiotic consortia. Strategies can be envisioned that benefit
both microorganisms and their hosts; for example, introducing into phage genomes certain genes that are involved in
nutrient biosynthesis (with direct benefits to the bacterial, and potentially also the human, host) or degradation
(potentially stabilizing the abundance and niches of beneficial microorganisms, especially during times of acute stress).

member of a community, lysogenic phages could be
introduced to promote a community structure that is
beneficial to both the human host and microbial community members (FIG. 3). For example, we could expand the
capacity of the gut microbiome to degrade dietary components99. Similarly, phages could be used to introduce
novel, beneficial traits to community members, such as
those involving nutrient biosynthesis. In these cases, it
may be difficult to introduce traits that are not purely
beneficial to the bacterial host of a lysogenic phage, as the
614 | SEPTEMBER 2012 | VOLUME 10

energetic effects of synthesizing an unnecessary protein
may impose a selection pressure.
Given the potential power and replicative nature of
phages, a number of questions must be addressed before
these viruses can be more widely adopted as therapeutics,
including issues related to biocontainment 98. Although
phages are frequently sold as viruses that ‘can only infect
bacteria’, their safety has yet to be completely defined.
The intravenous administration of phages (for example,
in the case of bacterial sepsis) is particularly complex

96
© 2012 Macmillan Publishers Limited. All rights reserved

www.nature.com/reviews/micro

F O C U S O N N E X T- G E N E R AT I O N S E Q U
NG
RE N
VC
I EIW
S

97

given the immunogenicity of some preparations and the
rapid clearance of phage particles by the reticuloendothelial system of the spleen100. It is tempting to assume that
other routes of administration, such as oral cocktails of
phages to target the human gut microbiome, would not
have such effects; however, phage DNA is detectable by
PCR and FISH (fluorescence in situ hybridization) in the
serum shortly after oral consumption of phages101. Other
studies have provided evidence of trans-placental passage
of phages102. There are data suggesting that enzymes transcribed from phage DNA can be expressed in mammalian cells103; this finding has even led to attempts to use
phages as gene therapy vectors104,105.
Despite these concerns, we are exposed to millions of
phages every day, including those from our own microbiota, without significant observable harm. Given this
fact, it is interesting to consider the potential therapeutic use of phages in the context of current efforts to
apply microbiome-directed therapies106. Questions that
can be asked include whether it is beneficial or detrimental for candidate probiotic bacterial taxa to possess
or lack prophages, or whether phages should be deliberately administered coincidently with or preceding the
introduction of a probiotic consortium in order to help
create a niche that promotes successful invasion and
engraftment of the consortium.

Future directions
Little experimental work has been carried out on the
ecology of phages in vivo. Germ-free mice and mice
monocolonized with different strains of Escherichia
coli, including strains that were isolated from children
with diarrhoea, have been used to examine the replication of T4 and T7 phages107,108. Models of the human
gut microbiota using gnotobiotic mice may not only
provide a better understanding of phage–bacterial host
dynamics, but also represent a potentially valuable tool
for establishing a preclinical pipeline designed to evaluate the feasibility of phage therapy. Recent work has
shown that transplanting intact, uncultured human gut
microbial communities (in the form of a faecal transplant) into gnotobiotic mice is efficient, and captures
the majority of the microbial diversity and microbiomeencoded functions that are present in the human donor’s
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community 109,110. Mice with replicated human gut microbiomes can be fed diets resembling those of the human
donor to explore diet–microbiome–phage interactions.
An additional refinement to this approach is to culture
and sequence collections of bacteria (some members of
which will contain prophages) from a given donor’s faecal sample and transplant these collections into recipient mice110. Various perturbations can be applied to the
gnotobiotic mice harbouring these microbiota (such
as changes in diet or manipulation of the immune system), and the effects of these perturbations on phage–
bacterium dynamics can be studied over time under
highly controlled conditions.
Yet another envisioned approach is to take cultured,
sequenced members of the human gut microbiota and
use these to assemble defined communities in formerly
germ-free mice. Preparing VLPs from human faecal
samples and introducing them into these mice would
allow investigators to directly determine the bacterialhost specificity of VLP-associated phages. This approach
could also allow researchers to assess the effects of the
presence or absence of a prophage in community members, the effects of the diet administered to the animals
and the contribution of phages to mammalian host
physiology, including immune function. The impact of
a staged phage attack on community structure and functions can also be defined in gnotobiotic animal models over time and as a function of location within the
length of the gut, where the available nutrient and energy
resources vary considerably.
These model systems should help us understand how
phages influence metabolism in the gut and how we can
use phages to manipulate human microbial communities.
This will almost certainly demand new and more efficient
methods for deliberately curing bacterial hosts of their
prophages. It may also require the application of wholegenome transposon mutagenesis methods married to
next-generation sequencing platforms111 to identify the
functional contributions of genes in a given prophage.
Although the journey ahead will certainly be demanding,
approaches are in hand (or can be envisioned) that will
help propel the ‘new age of phage’ forward so that longstanding questions can be addressed and new insights
can be obtained.
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